[go: up one dir, main page]

WO2022036050A1 - Systèmes et procédés pour sondes endovasculaires souples à l'échelle micrométrique pour l'enregistrement neuronal - Google Patents

Systèmes et procédés pour sondes endovasculaires souples à l'échelle micrométrique pour l'enregistrement neuronal Download PDF

Info

Publication number
WO2022036050A1
WO2022036050A1 PCT/US2021/045679 US2021045679W WO2022036050A1 WO 2022036050 A1 WO2022036050 A1 WO 2022036050A1 US 2021045679 W US2021045679 W US 2021045679W WO 2022036050 A1 WO2022036050 A1 WO 2022036050A1
Authority
WO
WIPO (PCT)
Prior art keywords
less
component
micrometers
electrical
equal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2021/045679
Other languages
English (en)
Inventor
Anqi Zhang
Charles M. Lieber
Emiri T. MANDEVILLE
Eng H. Lo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
General Hospital Corp
Harvard University
Original Assignee
General Hospital Corp
Harvard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by General Hospital Corp, Harvard University filed Critical General Hospital Corp
Publication of WO2022036050A1 publication Critical patent/WO2022036050A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/25—Bioelectric electrodes therefor
    • A61B5/279—Bioelectric electrodes therefor specially adapted for particular uses
    • A61B5/291—Bioelectric electrodes therefor specially adapted for particular uses for electroencephalography [EEG]
    • A61B5/293—Invasive
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
    • A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
    • A61B5/6876—Blood vessel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode

Definitions

  • the present disclosure generally relates to injectable electronics.
  • the subject matter of the present disclosure involves, in some cases, interrelated products, alternative solutions to a particular problem, and/or a plurality of different uses of one or more systems and/or articles.
  • Neuroelectronic interfaces allow communication between the brain and the external device. Many such interfaces have been developed with the goal of gathering different forms of neural information, with varying levels of invasiveness.
  • Non-penetrating recording electrodes such as electroencephalographic (EEG) and electrocorticographic (ECoG) electrodes are noninvasive but cannot achieve single-cell level resolution and are limited to recording from the surface of the brain.
  • EEG electroencephalographic
  • EoG electrocorticographic
  • invasive approaches such as transcranially implanted depth electrodes can achieve single-cell, single- spike resolution in deep brain regions, but require open- skull surgeries, and disrupt the neuron network during implantation. Accordingly, improvements for injectable electronics and neuroelectronic interfaces are needed.
  • the present disclosure generally relates to injectable electronics.
  • the subject matter of the present disclosure involves, in some cases, interrelated products, alternative solutions to a particular problem, and/or a plurality of different uses of one or more systems and/or articles.
  • the present disclosure is generally directed to a device for insertion into a blood vessel of a subject.
  • the device comprises a first component comprising a plurality of electrical elements; a second component comprising a plurality of electrically isolated contacts; and a joining component connecting the first component and the second component, wherein a portion of the joining component comprises a guidewire connecting to the first component, wherein the portion of the joining component comprising the guidewire has a mechanical stiffness of at least 30 nN m.
  • the present disclosure is generally directed to an article.
  • the article comprises a device comprising a first component comprising a plurality of electrical elements, a second component comprising a plurality of electrically isolated contacts, and a joining component connecting the first component and the second component; and a catheter containing at least a portion of the device.
  • the present disclosure is generally directed to methods of inserting a device into a blood vessel.
  • the method of inserting a device into a blood vessel comprises inserting at least a portion of a device into a blood vessel, the device having a maximum cross-sectional dimension of 100 micrometers, wherein the device comprises a first component comprising a plurality of electrical elements; a second component comprising a plurality of electrically isolated contacts; and a joining component connecting the first component and the second component.
  • the present disclosure is generally directed to methods of sensing neuron activities.
  • the method of sensing neuron activities comprises determining electrical activity in one or more neurons using a device positioned within a blood vessel adjacent to the one or more neurons, wherein the device comprises a first component comprising a plurality of electrical elements, a second component comprising a plurality of electrically isolated contacts, and a joining component connecting the first component and the second component.
  • the present disclosure is generally directed to a system.
  • the system comprises a subject; and a device inserted into a blood vessel of the subject, the device comprising a first component comprising a plurality of electrical elements, a second component comprising a plurality of electrically isolated contacts, and a joining component connecting the first component and the second component.
  • the present disclosure encompasses methods of making one or more of the embodiments described herein, for example, an injectable device as discussed herein. In still another aspect, the present disclosure encompasses methods of using one or more of the embodiments described herein, for example, an injectable device as discussed herein.
  • FIG. 1A-1C illustrate mesh implantation procedures, in accordance with one embodiment.
  • FIG. 1A illustrates insertion of microcatheter loaded with mesh electronics into the external carotid artery (ECA) stump.
  • FIG. IB illustrates retraction of the microcatheter.
  • FIG. 1C illustrates exposing of the mesh stem.
  • FIGs. 2A-2B illustrate an acute recording setup (FIG. 2A) and a chronic recording setup (FIG. 2B), in another embodiment.
  • FIGs. 3A-3C are schematics of endovascular implantation into the MCA (middle cerebral artery) and the ACA (anterior cerebral artery), in yet another embodiment.
  • FIG. 3A illustrates a microcatheter loaded with the mesh electronics is inserted from the ECA opening to the MCA/ ACA bifurcation.
  • FIGs. 3B-3C are images of the bottom of the dissected and perfused rat brains with meshes in MCA (FIG. 3B) and ACA (FIG. 3C).
  • FIGs. 4A-4E illustrate branch-selective implantation, in still another embodiment.
  • FIGs. 4A-4B show schematics of an endovascular mesh electronics probe.
  • FIG. 4C shows a graph illustrating branch- selectivity of the mesh.
  • FIG. 4D illustrates a side view of a rat brain with a mesh in MCA.
  • FIG. 4E illustrates acute in vivo 16-channel recording using mesh electronics injected into ACA.
  • FIGs. 5A-5E illustrate acute recording of epilepsy spikes, in one embodiment.
  • FIG. 5A is a schematic of penicillin injection into rat brains with meshes implanted in MCA and ACA.
  • FIGs. 5B and 5D illustrate penicillin-induced epilepsy recorded by a representative channel from meshes in MCA (FIG. 5B) vs. ACA (FIG. 5D).
  • FIGs. 5C and 5E show the number of spikes with amplitude over 1 mV per minute recorded by meshes in MCA (FIG. 5C) vs. ACA (FIG. 5E).
  • FIGs. 6A-6C illustrate acute recording of single-unit spikes, in another embodiment.
  • FIG. 6A shows periodic single-unit spikes recorded by a mesh in ACA.
  • FIG. 6B shows single-unit spikes sorted from the data shown in FIG. 6A.
  • FIG. 6C illustrates changes of firing frequency with different isoflurane concentration.
  • FIGs. 7A-7B show representative laser doppler flowmetry (LDF) of implantation in MCA (FIG. 7A) vs ACA (FIG. 7B), according to still another embodiment.
  • LDF laser doppler flowmetry
  • FIGs. 8A-8E illustrate chronic histology, in yet another embodiment.
  • FIG. 8A illustrates a digital camera image of a representative IgG-stained brain slice 28 days postimplantation in MCA.
  • FIG. 8B illustrates zoom-in views of the contralateral and ipsilateral MCA cross-sections from the H&E-stained slice from the regions highlighted by the larger boxes in FIG. 8A.
  • FIG. 8C shows MCA vessel wall thickness measured from H&E images of 5 slices that are 600 micrometers apart.
  • FIG. 8D illustrates confocal fluorescence microscopy images of the contralateral and ipsilateral cortexes from the regions highlighted by the smaller boxes in FIG. 8A.
  • FIG. 8E shows the number of microglia and astrocytes counted from fluorescence images of 5 slices that are 600 micrometers apart.
  • FIGs. 9A-9B illustrate a device in an un-deformed configuration (FIG. 9A) and a deformed configuration (FIG. 9B) in accordance with one embodiment.
  • FIG. 10 schematically illustrates a cross-section of a portion of a joining component, in one embodiment.
  • FIG. 11 schematically illustrates a cross-section of a device, in another embodiment.
  • the present disclosure generally relates to injectable electronics that can be inserted into a subject, e.g., into a blood vessel.
  • Some embodiments include a device comprising electrical elements that is injected into a subject, e.g., to allow for sensing of neurons and/or stimulating a response.
  • the device may be encapsulated partially by a catheter, for insertion into a subject.
  • the electrical elements may be in electrical communication with an external circuit board through electrical contacts on the device via a joining component.
  • the joining component comprises a guidewire that imparts appropriate properties (e.g., a mechanical stiffness of at least 30 nM m) to a portion of the device, for example, to allow insertion of the device into a blood vessel.
  • appropriate properties e.g., a mechanical stiffness of at least 30 nM m
  • Certain embodiments also relate to systems and methods of making and using such device. As mentioned, certain aspects are related to a device for inserting into a blood vessel of a subject.
  • the device may be configured in some embodiments such that it can be selectively inserted blood vessels, e.g., having various dimensions and/or tortuosities.
  • a device may be configured and sized to allow it to be inserted into a blood vessel having a maximum cross-sectional dimension of less than or equal to 100 micrometers, e.g., a size range previously inaccessible by other devices.
  • a portion of the joining component may comprise a guidewire.
  • the guidewire may have characteristics that may allow it to be inserted into a blood vessel, e.g., having certain dimensions and/or tortuosities.
  • the guidewire may have certain dimensions, mechanical stiffnesses, geometries, etc., as discussed herein.
  • the device may be configured such that the portion of the joining component comprising the guidewire connecting to the first component has a mechanical stiffness of at least 30 nN m, or other properties such as those discussed herein.
  • a catheter e.g., microcatheter
  • the device may be used to contain at least a portion of the device, for example, to aid insertion of the device into a blood vessel.
  • at least a portion of the device may be inserted into a blood vessel, for example, to sense an analyte, to apply an electrical stimulus, to determine an electrical signal, etc.
  • the blood vessel may be any blood vessel, e.g., such as a blood vessel in or near a subject’s brain.
  • a device within the blood vessel in a subject’s brain may be used to sense the electrical activity of a single neuron.
  • a device for insertion into a blood vessel of a subject may comprise a first component comprising a plurality of electrical elements, a second component comprising a plurality of electrically isolated contacts, and a joining component connecting the first component and the second component.
  • a portion of the joining component comprises a guidewire connecting to the first component.
  • FIG. 9A is a non-limiting representation of an example of such a device.
  • device 100 comprises a first component 10, a second component 20, and a joining component 30 that connects first component 10 and second component 20.
  • a portion of the joining component 30 comprises guidewire 31 connecting to first component 10.
  • the guidewire may be also present throughout the joining component, e.g., in both the portion of joining component connecting to the first component and the second component.
  • the joining component, including the guidewire extends along a center axis of the device.
  • joining component 30 may extend along a center axis of device 100.
  • FIGs. 4A- 4B show another non-limiting example of such a device, where a first component comprises a guidewire extending along a center axis of the first component, as shown in FIG. 4B.
  • the portion of the joining component comprising a guidewire may have a mechanical stiffness, e.g., bending stiffness, that allows the device to be inserted into a blood vessel.
  • the joining component may have a mechanical stiffness of at least 30 nN m.
  • the joining component may have a mechanical stiffness of at least 35 nN m, at least 70 nN m, at least 150 nN m, at least 250 nN m, at least 350 nN m, at least 450 nN m, at least 550 nN m, at least 650 nM m, at least 750 nN m, at least 850 nN m, at least 950 nN m, at least 1500 nN m, at least 2500 nN m, at least 3500 nN m, at least 4500 nN m, etc.
  • the joining component may have a mechanical stiffness of less than or equal to 5000 nN m, less than or equal to 4000 nN m, less than or equal to 3000 nN m, less than or equal to 2000 nN m, less than or equal to 1000 nN m, less than or equal to 900 nN m, less than or equal to 800 nN m, less than or equal to 700 nN m, less than or equal to 600 nN m, less than or equal to 500 nN m, less than or equal to 400 nN m, less than or equal to 300 nN m, less than or equal to 200 nN m, less than or equal to 100 nN m, less than or equal to 80 nN m, less than or equal to 60 nN m, less than or equal to 40 nN m, etc.
  • the guidewire may have a mechanical stiffness between 35 nN m and 4500 nN m, between 30 nN m and 200 nN m, between 150 nN m and 5000 nN m, etc.
  • the guidewire may have any suitable shape or geometry, e.g., that may be useful for allowing the guidewire to be inserted into a target blood vessel of a subject.
  • the guidewire may have the shape of a cylinder, a rectangular prism, a cone, etc., but is not limited to these shapes.
  • the guidewire has at least one or more cross-sectional dimensions, e.g., such as in a rectangular prism.
  • the guidewire may have a first cross-sectional dimension, e.g. width, and a second cross-sectional dimension, e.g., thickness.
  • the guidewire may have a width of at least 5 micrometers, at least 10 micrometers, at least 20 micrometers, at least 30 micrometers, at least 40 micrometers, at least 50 micrometers, at least 60 micrometers, at least 70 micrometers, at least 80 micrometers, at least 90 micrometers, etc.
  • the guidewire may have a width of less than or equal to 100 micrometers, less than or equal to 95 micrometers, less than or equal to 80 micrometers, less than or equal to 75 micrometers, less than or equal to 50 micrometers, less than or equal to 35 micrometers, less than or equal to 25 micrometers, less than or equal to 15 micrometers, less than or equal to 10 micrometers, less than or equal to 5 micrometers, etc. Combinations of these ranges are also possible in some embodiments; for example, the guidewire may have a width between 25 micrometers and 75 micrometers, between 5 micrometers and 100 micrometers, etc. Other ranges of width may be possible. In some cases, the width may allow insertion of the device into a blood vessel of a certain dimension, e.g., the width is smaller than the dimension of a blood vessel.
  • the guidewire may have a second cross-sectional dimension, e.g., a thickness.
  • the guidewire may have a thickness of at least 6 micrometers, at least 10 micrometers, at least 15 micrometers, at least 25 micrometers, at least 35 micrometers, at least 45 micrometers, at least 55 micrometers, at least 65, at least 75 micrometers, at least 85 micrometers, at least 95 micrometers, etc.
  • the guidewire may have a thickness of less than or equal to 100 micrometers, less than or equal to 90 micrometers, less than or equal to 80 micrometers, less than or equal to 70 micrometers, less than or equal to 60 micrometers, less than or equal to 50 micrometers, less than or equal to 40 micrometers, less than or equal to 30 micrometers, less than or equal to 20 micrometers, less than or equal to 10 micrometers, less than or equal to 5 micrometers, etc. Combinations of these ranges are also possible in some embodiments; for example, the guidewire may have a thickness of between 6 micrometers and 30 micrometers, between 10 micrometers and 35 micrometers, between 5 micrometers and 100 micrometers, etc. Other ranges of thickness may be possible. In some cases, the thickness may allow insertion of the device into a blood vessel of a certain dimension.
  • the guidewire may be configured to allow insertion of a portion of the device (e.g., a first component) into a blood vessel, for example, of a certain dimension and/or tortuosity.
  • a portion of the device e.g., a first component
  • tortuosity e.g., a certain dimension and/or tortuosity.
  • a guidewire having dimensions such as those described herein e.g., less than 100 micrometers
  • a guidewire of relatively low mechanical stiffness e.g., less than or equal to 200 nN m, or other stiffnesses such as those described herein
  • a flexible guidewire with a relatively high mechanical stiffness e.g., greater than or equal to 200 nN m, or other stiffnesses such as those described herein may be used.
  • the portion of the joining component may comprise additional components.
  • the portion of the joining component may comprise a bottom layer comprising a “bedding” polymer, a metal layer comprising metal leads or interconnects disposed on the bottom layer, a top layer comprising a coating polymer disposed on the metal layer, and a guidewire disposed on the top layer.
  • FIG. 10 A non-limiting representation is shown in FIG. 10. As shown, a cross-section of the portion of joining component connecting to the first component comprises bedding polymer layer 105, metal layer 110, coating polymer layer 115, and guidewire layer 120.
  • At least one of the bedding polymer layer, coating polymer layer, and guidewire layer comprises a photoresist such as described herein, e.g., SU-8.
  • a photoresist may be used in photolithographic techniques to pattern the aforementioned layers of the device.
  • materials other than photoresists may also be used in other embodiments.
  • the guidewire layer and/or other aforementioned layers may comprise polymers such as a polyimide (e.g., PI-2610, PI- 2611, etc.), which may be patterned into the corresponding layers via reactive ion etching.
  • Other polymers include those described herein.
  • the metal layer comprises a plurality of metal (e.g., gold) leads or interconnects, e.g., to allow electrical communication between the electrical elements in the first component and the isolated electrical contacts in the second component.
  • metal e.g., gold
  • interconnects e.g., to allow electrical communication between the electrical elements in the first component and the isolated electrical contacts in the second component.
  • Any suitable number of layers and/or arrangement of the layer and/or guidewire may be possible, as disclosed elsewhere herein.
  • some or all of the layers may have any suitable properties, e.g., dimensions, geometry, and/or mechanical stiffness, etc.
  • a portion of a joining component connected to the second component and/or a portion of the joining component in between the first and second components may comprise the same or different properties and/or arrangements of layers as the portion of the joining component connected to the first component, as disclosed herein.
  • the dimensions of each layer in these portions of the joining component may be the same or different as those in the portion of joining component connected to the first component, as previously discussed.
  • the first component comprises a mesh comprising a plurality of electrical elements.
  • FIG. 9A(i) shows a non-limiting example of a mesh in first component 10.
  • the first component e.g., the mesh
  • the first component may be configured to deform from a first maximum cross-sectional dimension to a second maximum cross-sectional dimension smaller than the first maximum cross-sectional dimension.
  • first component 10 may deform from first maximum cross-sectional dimension Wi to second maximum cross-sectional dimension W2, as a non-limiting example.
  • the mesh of the first component may be rolled up about a center axis of the first component (e.g., a guidewire in the joining component) in a deformed state.
  • the mesh of the first component may be in a deformed state before, during, or after insertion into a blood vessel.
  • the maximum cross-sectional dimensions of the first component may allow insertion of the first component into a blood vessel of a subject.
  • the blood vessel may have a maximum cross-sectional inner dimension of less than or equal to 500 micrometers, less than or equal to 300 micrometers, less than or equal to 200 micrometers, less than or equal to 100 micrometers, or other dimensions such as those described herein.
  • the second maximum cross-sectional dimension of the first component may be less than or equal to 100 micrometers.
  • the second maximum cross-sectional dimension may be less than or equal to 90 micrometers, less than or equal to 80 micrometers, less than or equal to 70 micrometers, less than or equal to 60 micrometers, less than or equal to 50 micrometers, less than or equal to 40 micrometers, less than or equal to 30 micrometers, less than or equal to 20 micrometers, less than or equal to 10 micrometers, less than or equal to 5 micrometers, less than or equal to 1 micrometer, less than or equal to 500 nm, less than or equal to 200 nm, or less than or equal to 100 nm, etc.
  • the first component comprises a plurality of electrical elements (e.g., electrodes) disposed in a mesh.
  • a portion of the first component e.g., the mesh, may comprise a photoresist, e.g., SU-8.
  • the mesh may comprise a periodic structure, in addition to a plurality of electrical elements.
  • FIG. 4 shows a non-limiting example with electrodes dispersed in a mesh.
  • FIG. 9A also shows a non-limiting representation of an exploded view of the periodic structure of the mesh in first component 10, as well at least one electrode 15 dispersed in the mesh.
  • the first component comprises a tapered end, e.g., to aid insertion of the device into a blood vessel.
  • FIG. 9A shows first component 10 comprising a tapered end.
  • the end does not need to be tapered, the end may also have any suitable shapes or dimension. Details of individual components (e.g., electrical elements, mesh, polymeric constructs, etc.) within the first component is disclosed elsewhere herein.
  • the first component has a length of at least 1.5 cm.
  • the length may be 1 cm or more, 2 cm or more, 3 cm or more, 5 cm or more, 7 cm or more, 9 cm or more, 11 cm or more, etc.
  • the angle may also be 15 cm or less, 13 cm or less, 10 cm or less, 8 cm or less, 6 cm or less, 4 cm or less, 2 cm or less, 1 cm or less, etc. Combinations of any of these length are also possible in some embodiments, e.g., the length may be between 1 cm and 3 cm, or between 2 cm and 9 cm, etc. Other lengths may also be possible.
  • the device comprises a first component comprising a plurality of electrical elements, a second component comprising a plurality of electrically isolated contacts, and a joining component connecting the first component and the second component.
  • the catheter comprises a micro-catheter.
  • the micro-catheter comprises a maximum cross-sectional inner dimension of less than or equal 200 micrometers. Other sizes may be possible.
  • the microcatheter may have a maximum cross-sectional inner dimension of less than or equal to 1000 micrometers, less than or equal to 900 micrometers, less than or equal to 800 micrometers, less than or equal to 700 micrometers, less than or equal to 600 micrometers, less than or equal to 500 micrometers, less than or equal to 400 micrometers, less than or equal to 300 micrometers, less than or equal to 200 micrometers, less than or equal to 100 micrometers, less than or equal to 80 micrometers, less than or equal to 60 micrometers, less than or equal to 40 micrometers, less than or equal to 20 micrometers, less than or equal to 10 micrometers, etc.
  • a portion of the device may fit, and/or be deformed to fit, within a volume of the catheter.
  • the first component and/or the second component may be deformed, e.g., curled around a joining component within the catheter.
  • the device may not necessarily need to be deformed to fit within a volume of the catheter.
  • the device may have a first maximum cross-sectional dimension in an un-deformed state that is less than the maximum cross-sectional inner dimension of the catheter.
  • at least a portion of the device or the entire device may be deformed to fit within the catheter.
  • a portion of the device e.g., first component 10 comprising a plurality of electrical elements in a deformable mesh
  • first component 10 comprising a plurality of electrical elements in a deformable mesh
  • second component 20 comprising electrical contact
  • a catheter e.g., as shown in FIG. 9B
  • the catheter e.g., micro -catheter
  • the catheter may have a length of at least 30 cm.
  • any lengths may be possible, depending on the necessary injection depth of the device in a subject, e.g., into a blood vessel of a subject.
  • the length of the catheter may be less than or equal to 100 cm, less than or equal to 80 cm, less than or equal to 75 cm, less than or equal to 70 cm, less than or equal to 65 cm, less than or equal to 60 cm, less than or equal to 55 cm, less than or equal to 50 cm, less than or equal to 45 cm, less than or equal to 40 cm, less than or equal to 30 cm, less than or equal to 25 cm, less than or equal to 20 cm, less than or equal to 10 cm, less than or equal to 5 cm, less than or equal to 3 cm, or less than or equal to 1 cm.
  • the length may be at least 1 cm, at least 3 cm, at least 5 cm, at least 10 cm, at least 15 cm, at least 20 cm, at least 25 cm, at least 30 cm, at least 35 cm, at least 40 cm, at least 45 cm, at least 50 cm, at least 55 cm, at least 60 cm, at least 65 cm, at least 70 cm, at least 75 cm, at least 80 cm, at least 100 cm, etc. Combinations of any of these are also possible; for example, the length may be between 5 cm and 20 cm. In some cases, the catheter may have a length that is the same as the length of the device.
  • the catheter may comprise any suitable material, e.g., biocompatible materials.
  • suitable material e.g., biocompatible materials.
  • materials may be selected including silicone rubber, nylon, polyurethane, polyethylene, polyimide, teflon, vinyl, polyethylene terephthalate, latex, thermoplastic elastomers, and combinations thereof.
  • other materials e.g., metals such as stainless steel, may also be used.
  • Certain aspects are related to methods of inserting at least a portion of the device disclosed herein into a blood vessel.
  • the at least a portion of the device may be the first component comprising the plurality of electrical elements.
  • the device may be contained within a catheter prior to insertion into the blood vessel.
  • the blood vessel is located in the brain.
  • the device is not limited to insertion into blood vessels within the brain; the device can be inserted into any other blood vessels suitable for insertion.
  • the device may be sized such that it can be inserted into capillaries or larger vessels (e.g., cardiac chambers, etc.) to allow for electrical recording and/or biochemical sensing.
  • Non-limiting examples of blood vessels in the brain include middle cerebral artery (MCA), anterior cerebral artery (ACA), etc.
  • the device can be inserted into MCA and/or ACA in the brain to detect neuron activities, as disclosed below.
  • the device has a maximum cross-sectional dimension of 100 micrometers.
  • the maximum cross-sectional dimension may be associated with a maximum cross-sectional dimension of the device in either an un-deformed or deformed state.
  • a portion of the device may be deformed to fit within a volume of the blood vessel.
  • the maximum cross- sectional dimension of the device (e.g., first component, second component, joining portion) in an un-deformed or deformed state may be less than or equal to 50 mm, less than or equal to 25 mm, less than or equal to 10 mm, less than or equal to 6 mm, less than or equal to 4 mm, less than or equal to 2 mm, less than or equal to 1 mm, less than or equal to 800 micrometers, less than or equal to 500 micrometers, less than or equal to 400 micrometers, less than or equal to 300 micrometers, less than or equal to 200 micrometers, less than or equal to 100 micrometers, less than or equal to 90 micrometers, less than or equal to 80 micrometers, less than or equal to 70 micrometers, less than or equal to 60 micrometers, less than or equal to 50 micrometers, less than or equal to 40 micrometers, less than or equal to 30 micrometers, less than or equal to 20 micrometers, less than or equal to 10 micrometers, less than or equal
  • the maximum cross-sectional dimension of the device (e.g., first component, second component, joining portion) in an un-deformed or deformed state may be greater than or equal to 5 micrometers, greater than or equal to 6 micrometers, greater than or equal to 10 micrometers, greater than or equal to 20 micrometers, greater than or equal to 30 micrometers, greater than or equal to 40 micrometers, greater than or equal to 50 micrometers, greater than or equal to 60 micrometers, greater than or equal to 80 micrometers, greater than or equal to 100 micrometers, greater than or equal to 200 micrometers, greater than or equal to 400 micrometers, greater than or equal to 500 micrometers, greater than or equal to 1 mm, greater than or equal to 2 mm, greater than or equal to 4 mm, greater than or equal to 6 mm, greater than or equal to 10 mm, or greater than or equal to 25 mm, etc. Combination of the abovereference ranges are possible (e.g., greater than or equal to 5 micrometers, greater than or
  • the maximum cross-sectional dimension of the device may be sized to allow insertion of the device into a blood vessel having a maximum cross-sectional inner dimension of less than or equal to 100 micrometers, a size that is typically inaccessible by other devices/articles.
  • a blood vessel having a maximum cross- sectional inner dimension of less than or equal to 100 micrometers is middle cerebral artery (MCA).
  • MCA middle cerebral artery
  • the device may be inserted into any suitable blood vessel with any suitable dimension.
  • the device may have a relatively small maximum cross- sectional dimension, e.g., such that the device may be inserted into capillaries. In some cases, at least a portion of the device may be inserted into a capillary, for example, to sense an analyte, to apply an electrical stimulus, to determine an electrical signal, etc. In some embodiments, the device may have a relatively small maximum cross-sectional dimension of less than or equal to 10 micrometers, less than or equal to 8 micrometers, or less than or equal to 6 micrometers. In some embodiments, the device may have a relatively small maximum cross-sectional dimension of greater than or equal to 5 micrometers, greater than or equal to 6 micrometers, or greater than or equal to 8 micrometers. Combination of the above-referenced ranges are also possible (e.g., greater than or equal to 5 micrometers and less than or equal to 10 micrometers). Other ranges are also possible.
  • the device may have a relatively large maximum cross- sectional dimension, such that the device may be inserted into larger blood vessels or chambers (e.g., cardiac chambers) within a subject.
  • the device may be inserted into larger blood vessels to monitor (e.g., to sense a biochemical analyte, to apply an electrical stimulus, to determine an electrical signal) a vascular implant.
  • the device described herein may be inserted into larger blood vessels as a stent (e.g., a polymer coated mesh electronic stent).
  • the device may have certain structural and/or material properties (e.g., stiffness, size, polymer coatings, etc.) that can advantageously result in a significantly less amount of chronic response during use.
  • the device may have a relatively large maximum cross-sectional dimension of greater than or equal to 0.1 mm, greater than or equal to 1 mm, greater than or equal to 2 mm, or higher.
  • the device may have a relatively large maximum cross-sectional dimension of up to 4 mm, up to 5 mm, up to 15 mm, up to 10 mm, up to 20 mm, up to 50 mm, or higher.
  • the plurality of electrical elements described herein comprises a plurality of sensing elements.
  • at least one of the electrical elements may be an electrode.
  • the electrode may be a sensing electrode.
  • the plurality of electrical elements comprises a plurality of electrical elements able to apply and electrical stimulus.
  • the electrode may be a stimulating electrode.
  • the electrodes may include portions of metals and/or semiconductors, such as those described herein.
  • Such metals may be exposed to the external environment (for example, the device once introduced into a subject), and accordingly, in some cases, such electrodes may be used to determine a physical property of a subject (e.g., determining neuron activities), and/or provide a stimulus (e.g., an electrical stimulus) to a subject.
  • a physical property of a subject e.g., determining neuron activities
  • a stimulus e.g., an electrical stimulus
  • the electrode may include metals such as aluminum, gold, silver, copper, molybdenum, tantalum, titanium, nickel, tungsten, chromium, palladium, platinum, as well as any combinations of these and/or other metals, and/or semiconductor materials such as silicon, gallium, germanium, diamond (carbon), tin, selenium, tellurium, boron, phosphorous, and/or other semiconductors described herein (including elemental and compound semiconductors).
  • the electrodes may include nanoscale wires and/or microscale wires, as disclosed elsewhere herein.
  • the electrical activity in one or more neurons can be determined using a device positioned within a blood vessel adjacent to the one or more neurons.
  • the device in certain embodiments may comprise a first component comprising a plurality of electrical elements, a second component comprising a plurality of electrically isolated contacts, and a joining component connecting the first component and the second component, or other devices such those discussed herein.
  • the device may have any properties disclosed herein, such as a portion of a joining component having a mechanical stiffness of at least 30 nN m, etc.
  • the one or more neurons may comprise neurons in the brain of a subject.
  • the one or more neurons may be any neurons, e.g., from central nervous system (CNS) or the peripheral nervous system (PNS), etc.
  • the blood vessels may be any blood vessels within or near the brain, spinal cord, gastrointestinal tract, etc.
  • determining electrical activity of the one or more neurons comprises sensing and recording single unit spikes (or multiple spikes) of neurons, e.g., across a blood vessel wall.
  • the distance between the device residing in the blood vessel and the one or more of neurons is less than or equal to 130 micrometers, less than or equal to 120 micrometers, less than or equal to 100 micrometers, less than or equal to 80 micrometers, less than or equal to 60 micrometers, etc.
  • the distance between the at least one or more electrical elements within the device residing in the blood vessel and the one or more of neurons is less than or equal to 130 micrometers.
  • the device may be inserted into a blood vessel, e.g., anterior cerebral artery (ACA) in the brain of a subject, to determine electrical activity of the one or more neurons in the brain.
  • ACA anterior cerebral artery
  • Certain aspects may be related to a system comprising a subject, and a device as discussed herein inserted into a blood vessel of the subject.
  • subjects include, but are not limited to, humans or non-humans, for example, a mammal such as a cow, sheep, goat, horse, rabbit, pig, mouse, rat, dog, cat, a primate (e.g., a monkey, a chimpanzee, etc.), or the like.
  • the living subject is a non-mammal such as a bird, an amphibian, or a fish.
  • the subject is genetically engineered. At least a portion of the device, e.g.
  • first component comprising the plurality of electrical elements may be inserted or introduced into blood vessels in certain organs within the subject, for example, within the brain, spinal cord, heart, or another organ of the living subject.
  • the organ is one that is electrically active, although this is not required, for example, if electrical elements able to determine chemical properties (e.g., pH), mechanical properties, or the like are used.
  • the device is not limited to inserting into blood vessel of a subject. In some cases, the device may be inserted into any region (e.g., organs, tissues, etc.) of the subject.
  • an external electrical cable (or other suitable connection) may be attached or detached to the device as desired, with minimal discomfort to the subject.
  • a portion of the device may extend externally, out of the body of the subject, to facilitate connection.
  • a portion of the device may comprise a circuit board that the electrical elements are in electrical communication with, for example, through one or more joining components.
  • the electrical elements may be allowed to remain within the blood vessel of a subject on an extended basis, with interactions with the device occurring externally of the subject in order to facilitate electrical communication with the electrical elements within the subject.
  • the electrical elements may be placed in electrical communication with a computer or other suitable device, for example, by attaching an electrical cable to a portion of the device, such as a circuit board, that is external to the subject.
  • the introduction of the electrical elements into a subject may be performed via injection, implantation, insertion, or other techniques such as those described herein. In some cases, the introduction may be performed surgically. In some embodiments, the electrical elements are injected into a subject from a catheter, e.g., via a needle or a syringe. Examples of suitable techniques for introducing electrical elements into a subject include those described below, as well as those described in Int. Pat. Apl. Pub. Nos. WO 2015/084805, WO 2015/199784, and WO 2017/024154, each of which is incorporated herein by reference in its entirety.
  • a portion of the device e.g., the first component comprising the plurality of electrical elements may be introduced into the subject, while a portion of the device is positioned outside of the subject, e.g., such that the device is accessible externally of the subject.
  • a portion of the device may first be introduced into the subject (for example, using a syringe), then connected to another portion of the device, e.g., one that is to be accessible externally of the subject.
  • the electrical elements in the first component positioned within the subject may be electrically connected to a device that can be attached to and detached from an external electrical cable as needed.
  • a cable may be attached to the device when sensing and/or stimulation of the subject is desired, while the cable may be detached afterwards. Multiple or repeated attachments and detachments may occur, while the injected electrical elements remain in the subject.
  • sensing and/or stimulating a subject may be performed as readily as attaching or detaching a cable to a suitable interface on the device.
  • many prior art techniques may not be sufficiently robust to permit multiple or repeated attachments and detachments, e.g., due to the delicacy of the electrical elements and/or the lack of a suitably robust interface available for connecting a suitable external electrical cable.
  • the electrical elements may form a first component of a device, optionally with other elements (for example, connecting wires, polymers, metals, or the like).
  • the device may also include a second component containing one or more isolated electrically contacts.
  • the device may also include a joining component that joins the first component and the second component.
  • more than one electric circuit may be present within the device, e.g., different contacts may be in electrical communication with different electrical elements, and in some cases, the electrical elements are individually addressable via the various contacts.
  • the second component may be connected to a circuit board to form the device, e.g., using clamps. Electrical cables can then be attached and detached from the device as needed.
  • the electrical elements may also be injected or otherwise introduced into a blood vessel of a subject, as mentioned. If more than one electrical element is introduced, the electrical elements may each independently be the same or different. Examples of electrical elements include, but are not limited to, the following. In one set of embodiments, some or all of the electrical elements may be electrodes. In one set of embodiments, for instance, some or all of the electrical elements may be nano scale electrical elements and/or or microscale electrical elements, such as those described in detail below. For example, nanoscale electrical elements may comprise nanowires and/or nanotubes. Other electrical elements, including those larger than the nanoscale, may also be used in certain cases, for example, microscale wires (e.g., having one or more cross-sectional dimensions of less than 1 mm, but being larger than a nanoscale wire).
  • microscale wires e.g., having one or more cross-sectional dimensions of less than 1 mm, but being larger than a nanoscale wire).
  • the electrical elements may each independently be connected in series, in parallel, or in a mesh, and/or isolated from each other.
  • a plurality of electrical elements may be arranged within a grid or mesh, e.g., of filaments.
  • the mesh may be formed from one or more filaments, and some or all of the filaments within the mesh may include one or more electrical elements, e.g., electrodes.
  • the grid or mesh may be substantially regularly arranged, for example, in a rectangular or parallelogram pattern, e.g., as shown in FIG. 9A.
  • the mesh comprises periodic structures formed from a combination of longitudinal filaments 16 and transverse filaments 17 (e.g., as shown in FIG. 9A(i)).
  • the mesh may adopt other, distorted configurations, although topologically, the filaments stay within their relative positions within the mesh.
  • some or all of the filaments within the mesh may include one or more electrical elements, such as electrodes, nanotubes, or nanowires, including those discussed herein.
  • the filaments within the mesh need all not necessarily include such electrical elements.
  • the filaments within the mesh may independently each contain conductive portions (for example, metals), and/or semiconducting portions (for example, silicon nanowires), and/or insulating portions (for example, polymers), such as those discussed in more detail herein.
  • the filaments within the mesh may include nanoscale filaments and/or microscale filaments.
  • FIG. 9A(i) shows an embodiment where at least one or more electrodes (e.g., electrode 15) are disposed on the filaments.
  • the at least one electrodes may be particularly advantageous to dispose the at least one electrodes on the longitudinal filaments (e.g., 16 in FIG. 9A), e.g., to reduce an overall width of the mesh in the first component, and/or ensure more freedom for the electrodes to localize and attach to and/or interact with the blood vessel wall as the device is inserted into a blood vessel.
  • any suitable number of electrodes may be disposed on the filaments.
  • each longitudinal filament comprises one electrode (e.g., as shown in FIG. 9A(i)).
  • the mesh may have any regular periodic arrangement of filaments.
  • the filaments are substantially straight.
  • the parallel groups may be arranged in any suitable angles relative to each other.
  • filaments in one group may have the same or different spacings or periodicities as filaments in other groups.
  • the filaments also may independently have the same or different average diameters relative to each other.
  • a group of filaments may be spaced or have repeat units such that the filaments of that group have an average spacing or periodicity of at least 1 micrometer, at least 2 micrometers, at least 3 micrometers, at least 5 micrometers, at least 10 micrometers, at least 20 micrometers, at least 30 micrometers, at least 50 micrometers, at least 60 micrometers, at least 100 micrometers, at least 200 micrometers, at least 300 micrometers, at least 500 micrometers, at least 1 mm, etc.
  • the filaments may also be spaced or have repeat units such that the filaments have an average spacing of no more than 1 mm, no more than 500 micrometers, no more than 300 micrometers, no more than 200 micrometers, no more than 100 micrometers, no more than 600 micrometers, no more than 50 micrometers, no more than 30 micrometers, no more than 20 micrometers, no more than 10 micrometers, no more than 5 micrometers, no more than 3 micrometers, no more than 2 micrometers, or no more than 1 micrometer.
  • the filaments within a group may have an average spacing of between 10 micrometers and 30 micrometers, or between 200 micrometers and 500 micrometers, or between 100 micrometers and 1 millimeters, etc.
  • two groups of filaments may meet at any suitable angle.
  • the two groups of filaments are orthogonal to each other, e.g., meeting at an angle of about 90°.
  • the angle may be 5° or more, 10° or more, 15° or more, 20° or more, 25° or more, 30° or more, 35° or more, 40° or more, 45° or more, 50° or more, 55° or more, 60° or more, 65° or more, 70° or more, 75° or more, 80° or more, or 85° or more, 95° or more, 105° or more, 115° or more, 125° or more, 135° or more, 145° or more, 155° or more.
  • the angle may also be 160° or less, 150° or less, 140° or less, 130° or less, 120° or less, 110° or less, 100° or less, 90° or less, 85° or less, 80° or less, 70° or less, 65° or less, 60° or less, 55° or less, 50° or less, 45° or less, 40° or less, 35° or less, 30° or less, 25° or less, 20° or less, 15° or less, 10° or less, or 5° or less. Combinations of any of these angles are also possible in some embodiments, e.g., the filaments may meet an angle of between 30° and 45°, or between 60° and 65°, or between 90° and 160°, etc.
  • a mesh may have various groups of filaments meeting at various angles, e.g., the mesh need not have only a single angle.
  • the joining component may have one or more electrical connections passing through and connecting the first component to the second component of the device. See, e.g., FIG. 9A.
  • the electrical connections may comprise, for example, metals or semiconductors, such as those described herein.
  • the electrical connections are parallel to each other.
  • the electrical connections may be isolated from each other in some cases, for example, separated by an insulating material (for example, a photoresist such as SU-8, or polymers including those described herein).
  • the joining component comprises a biocompatible material.
  • the joining component can have any suitable length.
  • the length may depend, at least in part, on the expected depth of injection or other introduction of electrical elements within a subject, e.g., such that at least a portion of the second component of the device is able to remain externally of the subject after introduction of the electrical elements.
  • the length of the joining component may be less than 100 cm, less than 80 cm, less than 75 cm, less than 70 cm, less than 65 cm, less than 60 cm, less than 55 cm, less than 50 cm, less than 45 cm, less than 40 cm, less than 30 cm, less than 25 cm, less than 20 cm, less than 10 cm, less than 5 cm, less than 3 cm, or less than 1 cm.
  • the length may be at least 1 cm, at least 3 cm, at least 5 cm, at least 10 cm, at least 15 cm, at least 20 cm, at least 25 cm, at least 30 cm, at least 35 cm, at least 40 cm, at least 45 cm, at least 50 cm, at least 55 cm, at least 60 cm, at least 65 cm, at least 70 cm, at least 75 cm, at least 80 cm, at least 100 cm, etc. Combinations of any of these are also possible; for example, the length may be between 5 cm and 20 cm, or between 9 and 25 cm.
  • the joining component may have a maximum cross-sectional dimension that is less than or equal to 500 micrometers, less than or equal to 400 micrometers, less than or equal to 300, less than or equal to 200 micrometers, less than or equal to 180 micrometers, less than or equal to 160 micrometers, less than or equal to 140 micrometers, less than or equal to 120 micrometers, less than or equal to 100 micrometers, less than or equal to 90 micrometers, less than or equal to 80 micrometers, less than or equal to 70 micrometers, less than or equal to 60 micrometers, less than or equal to 50 micrometers, less than or equal to 40 micrometers, less than or equal to 30 micrometers, less than or equal to 20 micrometers, less than or equal to 10 micrometers, less than or equal to 5 micrometers, less than or equal to 3 micrometers, less than or equal to 2 micrometers, less than or equal to 1 micrometer, etc.
  • the joining component may have any appropriate cross-sectional dimension, e.g.
  • the joining component may be made from materials similar to those in the first component of the device containing electrical elements (for example, comprising the same metals, the same polymers, etc.) and/or fabricated using the same or different techniques as those for forming the first component, as disclosed in later sections. In some cases, both the first component and the joining component are fabricated simultaneously.
  • the device may also have a second component that comprises one or more isolated electrical contacts. At least some of these electrical contacts may be used to connect the device to, for example, a circuit board. In some cases, more than one electrical connection to the circuit board may be desired, and thus, in some cases, there may be a plurality of electrically isolated contacts on the second component, e.g., a connection to one contact may be independent of another contact (although it should be understood that one or more electrically isolated contacts may be part of the same electrical circuit in some cases, e.g., one may act as a positive and the other as a negative or a ground, etc.). The electrical contacts may thus facilitate electrical communication between the electrical elements within the first component and the circuit board.
  • the device may have at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 12, at least 16, at least 20, at least 24, at least 32, at least 36, at least 40, at least 45, at least 50, at least 64, at least 100, at least 128, at least 200, at least 400, at least 600, at least 800, or at least 1000 or more contacts.
  • the contacts may be regularly spaced, e.g., within the device. This may be useful, for example, to allow for connection to the circuit board. For instance, a plurality of such contacts may be useful to allow at least some of the electrical elements to be individually addressable.
  • the contacts may have a spacing or gap of at least 0.2 mm, at least 0.3 mm, at least 0.4 mm, at least 0.5 mm, at least 0.6 mm, at least 0.7 mm, at least 0.8 mm, at least 0.9 mm, or at least 1 mm and/or no more than 1.1 mm, no more than 1.0 mm, no more than 0.9 mm, no more than 0.8 mm, no more than 0.7 mm, no more than 0.6 mm, no more than 0.5 mm, no more than 0.4 mm, no more than 0.3 mm, or no more than 0.2 mm between the contacts.
  • the spacing may be between 0.4 mm and 0.6 mm, between 0.9 mm and 1.1 mm, between 0.2 mm and 0.4 mm, etc. In some cases, the spacing may be about 0.5 mm or about 1 mm.
  • the isolated electrical contacts may have any suitable shape and/or size.
  • the contacts may be square or rectangular in certain cases.
  • the contacts may independently have substantially the same size, or different sizes.
  • the contacts may have an average area of no more than 0.001 mm 2 , 0.005 mm 2 , at least 0.01 mm 2 , 0.05 mm 2 , at least 0.1 mm 2 , at least 0.2 mm 2 , at least 0.3 mm 2 , at least 0.4 mm 2 , at least 0.5 mm 2 , at least 0.6 mm 2 , at least 0.7 mm 2 , at least 0.8 mm 2 , at least 0.9 mm 2 , at least 1 mm 2 , at least 1.1 mm 2 , at least 1.2 mm 2 , at least 1.3 mm 2 , at least 1.4 mm 2 , at least 1.5 mm 2 , at least 2 mm 2 , at least 3 mm 2 , at least 4 mm 2 , at least 5 mm 2 , etc
  • the contacts may have an average area of no more than 10 mm 2 , no more than 5 mm 2 , no more than 4 mm 2 , no more than 3 mm 2 , no more than 2 mm 2 , no more than 1.5 mm 2 , no more than 1.4 mm 2 , no more than 1.3 mm 2 , no more than 1.2 mm 2 , no more than 1.1 mm 2 , no more than 1.0 mm 2 , no more than 0.9 mm 2 , no more than 0.8 mm 2 , no more than 0.7 mm 2 , no more than 0.6 mm 2 , no more than 0.5 mm 2 , no more than 0.4 mm 2 , no more than 0.3 mm 2 , no more than 0.2 mm 2 , no more than 0.1 mm 2 , no more than 0.01 mm 2 , no more than 0.005 mm 2 , etc. Combinations of any of these are also possible.
  • the contacts may have an average area per contact of between 0.00
  • the electrical contacts in the second component are made from materials similar to those in the first component of the device containing electrical elements (for example, comprising the same metals, the same polymers, etc.) and/or fabricated using the same or different techniques as those for forming the first component.
  • the second component is fabricated simultaneously as the first component and/or the joining component.
  • the contacts are not made from materials similar to those in the first component or joining component of the device.
  • the electrical contacts may be formed from meshes similar to those discussed above (including having the dimensions and/or materials previously discussed above). Accordingly, in some cases, the filaments within the mesh may include nanoscale filaments and/or microscale filaments, although in other cases, the filaments within the mesh may include filaments larger than the nanoscale or microscale, e.g., in addition to or instead of nanoscale filaments and/or microscale filaments.
  • a plurality of filaments may be formed into groups of filaments having a regular periodic arrangement of filaments.
  • the filaments may be substantially straight.
  • the parallel groups may be arranged in any suitable angles relative to each other.
  • filaments in one group may have the same or different spacings or periodicities as filaments in other groups.
  • the filaments also may independently have the same or different average diameters relative to each other. It should be understood that if meshes are used as the contacts, these meshes may have the same or different dimensions and/or materials as meshes of the first component (if meshes are present).
  • FIG. 9A(iii) shows a non-limiting representation of one or more electrical contacts 25 separated by a mesh comprising a plurality of filaments 22.
  • a group of filaments may be spaced or have repeat units such that the filaments of that group have an average spacing or periodicity of at least 1 micrometer, at least 2 micrometers, at least 3 micrometers, at least 5 micrometers, at least 10 micrometers, at least 20 micrometers, at least 30 micrometers, at least 50 micrometers, at least 100 micrometers, at least 200 micrometers, at least 300 micrometers, at least 500 micrometers, at least 1 mm, etc.
  • the filaments may also be spaced or have repeat units such that the filaments have an average spacing of no more than 1 mm, no more than 500 micrometers, no more than 300 micrometers, no more than 200 micrometers, no more than 100 micrometers, no more than 50 micrometers, no more than 30 micrometers, no more than 20 micrometers, no more than 10 micrometers, no more than 5 micrometers, no more than 3 micrometers, no more than 2 micrometers, or no more than 1 micrometer. Combinations of any of these spacings or periodicities are also possible in various embodiments; for example, the filaments within a group may have an average spacing of between 10 micrometers and 30 micrometers, or between 200 micrometers and 500 micrometers, etc.
  • two groups of filaments may meet at any suitable angle.
  • the two groups of filaments are orthogonal to each other, e.g., meeting at an angle of about 90°.
  • the angle may be 5° or more, 10° or more, 15° or more, 20° or more, 25° or more, 30° or more, 35° or more, 40° or more, 45° or more, 50° or more, 55° or more, 60° or more, 65° or more, 70° or more, 75° or more, 80° or more, or 85° or more.
  • the angle may also be 90° or less, 85° or less, 80° or less, 75° or less, 70° or less, 65° or less, 60° or less, 55° or less, 50° or less, 45° or less, 40° or less, 35° or less, 30° or less, 25° or less, 20° or less, 15° or less, 10° or less, or 5° or less. Combinations of any of these angles are also possible in some embodiments, e.g., the filaments may meet an angle of between 30° and 45°, or between 60° and 65°.
  • a mesh may have various groups of filaments meeting at various angles, e.g., the mesh need not have only a single angle.
  • the contacts may have any shape or structure, for example, square, rectangular, circular, trapezoidal, or the like. In some instances, the contacts have a shape or structure that allows a suitable electrical connection to be made to the contact, e.g., such that the contact is in electrical connection with a circuit board, an electrical cable, or the like. For example, the contact may have a shape that allows a clamp connection or a crimp connection to be made between the contact and a circuit board.
  • the contact may have a substantially solid structure, or a porous structure.
  • the first component and the second component of the device may be introduced into a subject using a catheter connected to a syringe.
  • at least part of the second component of the device may initially be collapsed to be able to fit through the catheter, then after introduction or injection of the first component, the second component may be expanded to allow connection, for example, to an electrical apparatus to form the device.
  • the contacts may be deformed, e.g., folded, curled, or otherwise mechanically manipulated, so as to be able to fit the catheter.
  • a plunger on a syringe may be pushed down slowly to inject the portion of the device contained within the catheter into the blood vessel.
  • the device contained within the catheter may also be inserted into other regions beside blood vessel in a subject. Any suitable regions within a subject, both living or non-living, may be possible.
  • the backing layer may be useful, e.g., to provide structural integrity to the contacts.
  • the backing layer may comprise tape, such as dicing tape or electrical tape, or the backing layer may comprise a polymer, such as polyvinyl chloride, polyethylene, a polyolefin, or the like.
  • the backing layer to the contacts may be applied after introduction of the electrical elements to the subject, for example, after the electrical contacts have passed through a catheter.
  • the electrical contacts may be physically connected to a circuit board (e.g., a printed circuit board), or other electrical apparatus, e.g., to produce an electrical connection between the contacts and the circuit board or other electrical apparatus.
  • the electrical apparatus may have one or more suitable electrical connections for connection to the contacts of the second component.
  • the electrical apparatus may have at least 2, at least 3, at least 4, at least 5, at least 6, at least 7, at least 8, at least 12, at least 16, at least 20, at least 24, at least 32, at least 36, at least 40, at least 45, at least 50, at least 64, at least 100, at least 128, at least or more electrical connections for connection to the contacts.
  • the electrical contacts may be made using one or more electrical connections. Examples include solderless electrical connectors, for example, crimp connectors, clamp connectors, screws, or the like. As other examples, solder could be used to electrically connect the contacts to the circuit board. The type of connection may each independently be the same or different for each contact. In some cases, the circuit board (or other electrical apparatus) may have a spacing of electrical connections that substantially matches the contacts, e.g., to allow connection between the electrical connections and the contacts in one-to-one correspondence.
  • Circuit boards and other similar electrical apparatuses may be custom-made, or a variety of circuit boards can be readily obtained commercially, e.g., having various methods for connecting to electrical contacts, including clamp or crimp connectors. Circuit boards and other similar electrical apparatuses may also be obtained in a variety of sizes and materials.
  • the circuit board (or other electrical apparatus) may have a maximum linear dimension of less than 50 cm, less than 40 cm, less than 30 cm, less than 25 cm, less than 20 cm, less than 15 cm, less than 10 cm, less than 5 cm, or less than 3 cm, and/or a weight of less than 1 kg, less than 500 g, less than 300 g, less than 100 g, less than 50 g, less than 30 g, less than 10 g, less than 5 g, less than 3 g, less than 2 g, or less than 1 g.
  • a maximum linear dimension less than 50 cm, less than 40 cm, less than 30 cm, less than 25 cm, less than 20 cm, less than 15 cm, less than 10 cm, less than 5 cm, or less than 3 cm, and/or a weight of less than 1 kg, less than 500 g, less than 300 g, less than 100 g, less than 50 g, less than 30 g, less than 10 g, less than 5 g, less than 3 g, less than 2 g
  • a printed circuit board may be used that has a size and weight such that it can be carried around by a mouse or rat without substantial impairment (e.g., due to its size or weight).
  • the apparatus may have a size and/or weight that it can be carried around by a subject (e.g., if the subject is living, or mobile).
  • the circuit board may also contain other functionalities, for example, digital multiplexing, wireless communications, signal processing, or the like.
  • the circuit board or other similar electrical apparatus may be immobilized relative to the subject, e.g., to facilitate portability and/or reduce impairment to the subject.
  • the apparatus may be directly immobilized onto a living subject, e.g., on the skin of the subject, or attached to a bone or other portion of the subject (e.g., as shown in FIG. 2).
  • the apparatus may be attached to a living or non-living subject using cement, cyanoacrylates, polymethylmethacrylates or other glues or adhesives, or the apparatus may be screwed onto the subject, e.g., using screws, wires, nails, or the like.
  • the apparatus may also be immobilized on a more temporary basis, for example, using slings, wraps, fabric, string, magnets, or the like to immobilize the apparatus to the subject, for example, by tying or binding the apparatus to the subject.
  • electrical elements may be introduced into a subject via injection, for example through a catheter.
  • a catheter such as a microcatheter.
  • a first component e.g., comprises one or more electrical elements such electrodes, nanoscale wires, and/or microscale wires
  • a second component e.g., comprising one or more electrical contacts
  • a joining component may be contained within a catheter for injection into a subject.
  • a circuit board or other electrical apparatus may be attached to the second component, e.g., using one or more electrical contacts, as discussed above.
  • the portions of the device within the catheter may be shaped to be cylindrical or curved, and/or the portions may be compressed to fit inside the catheter, although the device may be able to expand after exiting the catheter or additional component attached, e.g., as discussed herein.
  • the catheter is cylindrical, although the catheter may be noncylindrical in other cases.
  • the catheter may be tapered or beveled in some embodiments.
  • the catheter is hollow.
  • the catheter has a circular cross-section. However, in other cases, the catheter may not have a circular cross-section.
  • the portions of the device may pass through the catheter using any suitable method.
  • the portions may fully pass through the catheter, or in some cases, the portions may only partially pass through the catheter such that part of the device remains within the catheter.
  • the portions may be fully or partially expelled or urged from the tube using suitable forces, pressures, mechanisms, or apparatuses.
  • the portions may be expelled using a microinjection device.
  • the portions may be manually expelled, e.g., by pushing the plunger of a syringe.
  • fluids liquids or gases
  • water or saline may be added to the catheter to assist in expulsion.
  • a pump or other fluid source may be used to introduce fluid into the catheter.
  • a pump may pump fluid into the catheter (or through tubing or other fluidic channels) into the catheter to cause portions of the device to be expelled therefrom (e.g., partially or fully).
  • the portions injected into the subject may be injected at a controlled rate and/or with controllable position, for example, by controlling the pressure or flow rate of fluid from the pump.
  • the catheter may be inserted into a target such that portions of the device are expelled directly into the target.
  • the catheter may be inserted into a subject, e.g., into the blood vessel of a subject, such as those described herein.
  • the device may be expelled from the catheter such that the device at least partially penetrates into the blood vessel, e.g., the first component of the device containing electrical elements.
  • the portions of the device when inserted into the catheter, is constrained or compressed in some fashion such that, upon expulsion (fully or partially), those portions are able to at least partially expand.
  • the device may include a network that is rolled to form a cylinder (for example, a mesh containing electrical elements); upon expulsion, those portions are able to at least partially unroll and expand.
  • the portions are able to spontaneously expand, e.g., upon exiting the catheter. The expansion may occur rapidly, or on longer time scales.
  • the portions may unfold, or portions may uncompress, upon exiting a catheter.
  • the portions may expand to reach its original shape.
  • the portions may substantially return to their original shape after about 24 hours, after about 48 hours, or after about 72 hours. In certain embodiments, it may take longer for the portions to substantially return to its original shape, e.g., after 1 week, after 2 weeks, after 3 weeks, after 4 weeks, after 5 weeks, after 6 weeks, etc.
  • the portions may not necessarily return to its original shape, e.g., inherently, and/or due to the matter that the portions were injected or introduced into. For example, the presence of tissue (or other matter) may prevent the portions from fully expanding back to its original shape after insertion.
  • the portions may be expelled or urged from a catheter (or other suitable carrier) such that the portions are not significantly distorted, e.g., due to mechanical resistance offered by the medium that the portions are being inserted into.
  • the portions may be expelled or urged from a tube without substantially altering the position of those portions, relative to the medium. This may be useful, for example, to prevent or minimize compressive forces on those portions as it encounters the medium, e.g., which may deform or “crumple” those portions.
  • those portions may be “at rest” relative to the medium while the catheter is removed. In other embodiments, however, there may be some relative motion, e.g., due to forces involved in removing the catheter and/or urging the portions out of the catheter, movement of the medium (e.g., if the medium is alive), etc. In some cases, the motion may be less than about 10 cm/s, less than about 5 cm/s, less than about 3 cm/s, less than amount 1 cm/s, less than about 5 mm/s, less than about 3 mm/s, less than about 1 mm/s, less than about 0.5 mm/s, less than about 0.3 mm/s, or less than about 0.1 mm/s.
  • the position of those portions, relative to the medium may not change substantially, or the position may change by no more than about 40%, no more than about 35%, no more than about 30%, no more than about 25%, no more than about 20%, no more than about 15%, no more than about 10%, no more than about 5%, no more than about 2%, or no more than about 1%, relative to the length of those portions.
  • the position of those portions of the device, relative to the medium may change by no more than about 1 mm, no more than about 800 micrometers, no more than about 500 micrometers, no more than about 400 micrometers, no more than about 300 micrometers, no more than about 200 micrometers, no more than about 100 micrometers, no more than about 80 micrometers, no more than about 50 micrometers, no more than about 30 micrometers, no more than about 20 micrometers, no more than about 10 micrometers, no more than about 5 micrometers, etc.
  • the rates may differ by no more than about 40%, no more than about 35%, no more than about 30%, no more than about 25%, no more than about 20%, no more than about 15%, no more than about 10%, no more than about 5%, no more than about 2%, or no more than about 1%, relative to the slower of the two rates. In one embodiment, the rates are substantially equal.
  • a gas or a liquid may be present within the catheter.
  • the catheter may contain a liquid to facilitate expulsion of the device, or a liquid to assist in movement of the portions of the device out of the catheter, or into the target.
  • the catheter may include a liquid such as saline, which can be injected into a subject, e.g., along with the device.
  • the fluid may also contain one or more cells, which may be inserted or injected into a target along with those portions of the device. If the target is a living subject or biological tissue, the cells may be autologous, heterologous, or homologous to the tissue or to the subject.
  • the device may comprise one or more electrical networks comprising electrical elements and/or conductive pathways in electrical communication with the electrical elements.
  • a first component of a device may comprise one or more electrical elements, and one or more electrical networks in electrical communication with those electrical elements. These may be in electrical communication with one or more contacts in a second component of the device, e.g., for attachment to a circuit board or other electrical apparatus, optionally via a joining component.
  • various portions of the device may include conductive pathways, separated by insulating materials, to allow such electrical communication to occur.
  • the insulating materials may also be biocompatible and/or biodegradable.
  • at least some of the conductive pathways may also provide mechanical strength to portions of the device, and/or there may be polymeric or metal constructs that are used to provide mechanical strength to portions of the device. The same or different materials may be used in different portions of the device.
  • a portion of the device may be flexible in some cases, e.g., the device may be able to bend or flex.
  • a portion may be bent or deformed (i.e., distorted) by a volumetric displacement of at least about 5%, about 10%, or about 20% (relative to the undisturbed volume), without causing cracks and/or breakage within the device.
  • the portion can be distorted such that about 5%, about 10%, or about 20% of the mass of the portion has been moved outside the original surface perimeter of the portion, without causing failure (e.g., by breaking or cracking of the portion, disconnection of portions of the electrical network, etc.).
  • portions of the device may be bent or flexed as described above by an ordinary human being without the use of tools, machines, mechanical device, excessive force, or the like.
  • a flexible portion may be more biocompatible due to its flexibility, and the device may be treated as previously discussed to facilitate its insertion into a tissue.
  • a portion of the device may be non-planar in some cases, e.g., curved as previously discussed.
  • a portion of the device may be substantially U-shaped or cylindrical, and/or have a shape and/or size that is similar to a hypodermic needle.
  • the portions of the device may be able to be placed into a catheter. As discussed herein, those portions of the device can then be inserted or injected out of the catheter upon application of suitable forces and/or pressures, for instance, such that those portions can be inserted or injected into other matter.
  • portions of the device may be injected into a blood vessel of a subject, e.g., a first component containing one or more electrical elements.
  • the device may comprise a periodic structure comprising electrical elements.
  • the device may comprise a mesh or other two-dimensional array of electrical elements and/or other conductive pathways.
  • the mesh may include a first set of conductive pathways, generally parallel to each other, and a second set of conductive pathways, generally parallel to each other.
  • the first set and the second set may be orthogonal to each other, or they may cross at any suitable angle.
  • the sets may cross at a 30° angle, a 45 0 angle, or a 60 0 angle, or any other suitable angle.
  • Mesh structures of the device may be particularly useful in certain embodiments.
  • the period may be of any suitable length.
  • the length of a unit cell within the periodic structure may be less than about 500 micrometers, less than about 400 micrometers, less than about 300 micrometers, less than about 200 micrometers, less than about 100 micrometers, less than about 80 micrometers, less than about 60 micrometers, less than about 50 micrometers, less than about 40 micrometers, less than about 30 micrometers, less than about 20 micrometers, less than about 10 micrometers, etc.
  • the device may contain one or more polymeric constructs, e.g., within a first component, second component, and/or joining component.
  • the polymeric constructs typically comprise one or more polymers, e.g., photoresists, biocompatible polymers, biodegradable polymers, etc., and optionally may contain other materials, for example, metal leads or other conductive pathway materials.
  • the polymeric constructs may be separately formed then assembled into the device, and/or the polymeric constructs may be integrally formed as part of the device, for example, by forming or manipulating (e.g. folding, rolling, etc.) the polymeric constructs into a 3-dimensional structure that defines the device.
  • the polymeric constructs have the form of fibers or filaments.
  • the polymeric constructs may have one dimension that is substantially longer than the other dimensions of the polymeric construct.
  • the fibers can in some cases be joined together to form a network or mesh of fibers.
  • a device may contain a plurality of fibers that are orthogonally arranged to form a regular network of polymeric constructs.
  • the polymeric constructs need not be regularly arranged.
  • the polymer constructs may have the form of fibers or other shapes. In general, any shape or dimension of polymeric construct may be used to form a device.
  • some or all of the polymeric constructs have a smallest dimension or a largest cross-sectional dimension of less than about 5 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1 micrometer, less than about 700 nm, less than about 600 nm, less than about 500 nm, less than about 300 nm, less than about 200 nm, less than about 100 nm, less than about 80 nm, less than about 50 nm, less than about 30 nm, less than about 10 nm, less than about 5 nm, less than about 2 nm, etc.
  • a polymeric construct may also have any suitable cross- sectional shape, e.g., circular, square, rectangular, polygonal, elliptical, regular, irregular, etc. Examples of methods of forming polymeric constructs, e.g., by lithographic or other techniques, are discussed below.
  • the polymeric constructs can be arranged such that the device is relatively porous, e.g., such that the device does not obstruct blood flow within a blood vessel and increasing risks of stroke in a subject.
  • a non-limiting example of a porous region may be the porous mesh region shown in the first component in FIG. 9A (i).
  • the polymeric constructs may be constructed and arranged within the device such that the device has an open porosity of at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, at least about 97, at least about 99%, at least about 99.5%, or at least about 99.8%.
  • the “open porosity” is generally described as the volume of empty space within the device divided by the overall volume defined by the device, and can be thought of as being equivalent to void volume.
  • the open porosity includes the volume within the device to which cells can access.
  • the device does not contain significant amounts of internal volume to which the cells are incapable of addressing, e.g., due to lack of access and/or pore access being too small.
  • a “two-dimensional open porosity” may also be defined, e.g., of a device that is subsequently formed or manipulated into a 3-dimensional structure.
  • the two- dimensional open porosities of a device can be defined as the void area within the two- dimensional configuration of the device (e.g., where no material is present) divided by the overall area of device, and can be determined before or after the device has been formed into a 3 -dimensional structure.
  • a device may have a two- dimensional open porosity of at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, at least about 97, at least about 99%, at least about 99.5%, or at least about 99.8%, etc.
  • the device may have an areal mass density of less than about 10 micrograms/cm 2 , less than about 5 micrograms/cm 2 , less than about 1 micrograms/cm 2 , less than about 0.5 micrograms/cm 2 , less than about 0.3 micrograms/cm 2 , less than about 0.1 micrograms/cm 2 , less than about 0.05 micrograms/cm 2 , less than about 0.03 micrograms/cm 2 , less than about 0.01 micrograms/cm 2 , less than about 0.005 micrograms/cm 2 , or less than about 0.003 micrograms/cm 2 .
  • the porosity of a device can be defined in some embodiments by one or more pores. Pores that are too small can hinder or restrict blood flow.
  • the device may have an average pore size of at least about at least about 5 micrometers, at least about 10 micrometers, at least about 30 micrometers, at least about 50 micrometers, at least about 70 micrometers, at least about 90 micrometers, at least about 100 micrometers, at least about 200 micrometers, at least about 400 micrometers, at least about 600 micrometers, or at least about 1mm.
  • the device may have an average pore size of no more than about 800 micrometers, no more than about 500 micrometers, no more than about 300 micrometers, no more than about 250 micrometers, no more than about 150 micrometers, no more than about 100 micrometers, no more than about 75 micrometers, no more than about 55 micrometers, no more than about 35 micrometers, or no more than about 15 micrometers. Combinations of these are also possible, e.g., in one embodiment, the average pore size is at least about 100 micrometers and no more than about 1 mm, or at least about 30 micrometers to 100 micrometers. In addition, larger or smaller pores than these can also be used in a device in certain cases. Pore sizes may be determined using any suitable technique, e.g., through visual inspection (e.g., of microscope images), BET measurements, or the like.
  • one or more of the polymers forming a polymeric construct may be a negative photoresist.
  • photoresists are typically used in lithographic techniques, which can be used as discussed herein to form the polymeric construct.
  • the negative photoresist may be chosen for its ability to react to light to become substantially insoluble (or substantially soluble, in some cases) to a photoresist developer.
  • photoresists that can be used within a polymeric construct include, but are not limited to, SU-8, AZ 15nXT, AZ 125 nXT, AZ nEOF 2000 Series, KMPR, UVN-30, ma-N 1400 Series, ma-N 2400 Series or the like.
  • photoresists are available commercially.
  • materials other than photoresists may also be used in other embodiments.
  • etching methods such as reactive ion etching may be used to form the polymeric construct.
  • any suitable polymers e.g., polyimide capable of being etched may be used.
  • a polymeric construct may also contain one or more polymers that are biocompatible and/or biodegradable, in certain embodiments.
  • a polymer can be biocompatible, biodegradable, or both biocompatible and biodegradable, and in some cases, the degree of biodegradation or biocompatibility depends on the physiological environment to which the polymer is exposed to.
  • biocompatible and/or biodegradable polymers include, but are not limited to, poly(lactic-co-glycolic acid), polylactic acid, polyglycolic acid, poly(methyl methacrylate), poly(trimethylene carbonate), collagen, fibrin, polysaccharidic materials such as chitosan or glycosaminoglycans, hyaluronic acid, polycaprolactone, and the like.
  • the polymers and other components forming the device can also be used in some embodiments to provide a certain degree of flexibility to the device, which can be quantified as a mechanical stiffness (e.g., bending stiffness) per unit width of polymer construct.
  • the overall device may have a mechanical stiffness of at least 20 nN m, at least 30 nN m, at least 70 nN m, at least 150 nN m, at least 250 nN m, at least 350 nN m, at least 450 nN m, at least 550 nN m, at least 650 nM m, at least 750 nN m, at least 850 nN m, at least 950 nN m, at least 1500 nN m, at least 2500 nN m, at least 3500 nN m, at least 4500 nN m, etc.
  • the joining component may have a mechanical stiffness of less than or equal to 5000 nN m, less than or equal to 4000 nN m, less than or equal to 3000 nN m, less than or equal to 2000 nN m, less than or equal to 1000 nN m, less than or equal to 900 nN m, less than or equal to 800 nN m, less than or equal to 700 nN m, less than or equal to 600 nN m, less than or equal to 500 nN m, less than or equal to 400 nN m, less than or equal to 300 nN m, less than or equal to 200 nN m, less than or equal to 100 nN m, less than or equal to 80 nN m, less than or equal to 60 nN m, less than or equal to 40 nN m, etc.
  • the guidewire may have a mechanical stiffness between 35 nN m and 4500 nN m, between 30 nN m and 200 nN m, between 150 nN m and 5000 nN m, etc.
  • a device may have any appropriate stiffness, e.g., such that the device can be readily inserted into a catheter and/or blood vessel, as discussed herein.
  • the device can include a 2-dimensional structure that is formed into a final 3-dimensional structure, e.g., by folding or rolling the structure.
  • the 2-dimensional structure can be described as having an overall length, width, and height, the overall length and width of the structure may each be substantially greater than the overall height of the structure.
  • the 2-dimensional structure may also be manipulated to have a different shape that is 3 -dimensional, e.g., having an overall length, width, and height where the overall length and width of the structure are not each substantially greater than the overall height of the structure.
  • the structure may be manipulated to increase the overall height of the material, relative to its overall length and/or width, for example, by folding or rolling the structure.
  • a relatively planar sheet of material (having a length and width much greater than its thickness) may be rolled up into a catheter and/or a blood vessel, such that the catheter and/or blood vessel has an overall length, width, and height of relatively comparable dimensions to the device.
  • the 2-dimensional structure may comprise one or more electrical elements (e.g., electrodes) and one or more polymeric constructs formed into a 2-dimensional structure or network that is subsequently formed into a 3-dimensional structure.
  • the 2-dimesional structure may be rolled or curled up to form the 3-dimesional structure, or the 2-dimensional structure may be folded or creased one or more times to form the 3-dimesional structure.
  • Such manipulations can be regular or irregular.
  • the manipulations are caused by pre-stressing the 2- dimensional structure such that it spontaneously forms the 3-dimensional structure, although in other embodiments, such manipulations can be performed separately, e.g., after formation of the 2-dimensional structure.
  • the device may include one or more metal leads (i.e., interconnects), or other conductive pathways.
  • the metal leads or conductive pathways may provide mechanical support, and/or one or more metal leads can be used within a conductive pathway to an electrical element, such as an electrode, a nanoscale wire, and/or microscale wire.
  • the metal lead may directly physically contact the electrical elements and/or there may be other materials between the metal lead and the electrical elements that allow electrical communication to occur.
  • one or more metal leads or other conductive pathways may extend such that the device can be connected to external electrical circuits, computers, or the like, e.g., using one or more electrical contacts as discussed herein.
  • Metal leads are useful due to their high conductance, e.g., such that changes within electrical properties obtained from the conductive pathway can be related to changes in properties of the electrical elements, rather than changes in properties of the conductive pathway.
  • changes within electrical properties obtained from the conductive pathway can be related to changes in properties of the electrical elements, rather than changes in properties of the conductive pathway.
  • metal leads it is not a requirement that only metal leads be used, and in other embodiments, other types of conductive pathways may also be used, in addition or instead of metal leads.
  • metal leads can be used, in various embodiments.
  • the metals used within a metal lead may include aluminum, gold, silver, copper, molybdenum, tantalum, titanium, nickel, tungsten, chromium, palladium, platinum, as well as any combinations of these and/or other metals.
  • the metal can be chosen to be one that is readily introduced into the device, e.g., using techniques compatible with lithographic techniques.
  • lithographic techniques such as e-beam lithography, photolithography, X-ray lithography, extreme ultraviolet lithography, ion projection lithography, etc. may be used to layer or deposit one or more metals on a substrate.
  • the thickness of a metal layer comprising metal leads or interconnects may be less than about 5 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1 micrometer, less than about 700 nm, less than about 600 nm, less than about 500 nm, less than about 300 nm, less than about 200 nm, less than about 100 nm, less than about 80 nm, less than about 50 nm, less than about 30 nm, less than about 10 nm, less than about 5 nm, less than about 2 nm, etc.
  • the thickness of the layer may also be at least about 10 nm, at least about 20 nm, at least about 40 nm, at least about 60 nm, at least about 80 nm, or at least about 100 nm.
  • the thickness of a layer may be between about 40 nm and about 100 nm, between about 50 nm and about 80 nm.
  • more than one metal can be used within a metal lead.
  • two, three, or more metals may be used within a metal lead.
  • the metals may be deposited in different regions or alloyed together, or in some cases, the metals may be layered on top of each other, e.g., layered on top of each other using various lithographic techniques.
  • a second metal may be deposited on a first metal, and in some cases, a third metal may be deposited on the second metal, etc. Additional layers of metal (e.g., fourth, fifth, sixth, etc.) may also be used in some embodiments.
  • the metals can all be different, or in some cases, some of the metals (e.g., the first and third metals) may be the same.
  • Each layer may independently be of any suitable thickness or dimension, e.g., of the dimensions described above, and the thicknesses of the various layers can independently be the same or different.
  • dissimilar metals are layered on top of each other, they may be layered in some embodiments in a “stressed” configuration (although in other embodiments they may not necessarily be stressed).
  • chromium and palladium can be layered together to cause stresses in the metal leads to occur, thereby causing warping or bending of the metal leads.
  • the amount and type of stress may also be controlled, e.g., by controlling the thicknesses of the layers. For example, relatively thinner layers can be used to increase the amount of warping that occurs.
  • layering metals having a difference in stress e.g., film stress
  • stresses within the metal which can cause bending or warping as the metals seek to relieve the stresses.
  • mismatches are undesirable because they could cause warping of the metal leads and thus, the device.
  • mismatches may be desired, e.g., so that the device can be intentionally deformed to form a 3-dimensional structure, as discussed below.
  • the deposition of mismatched metals within a lead may occur at specific locations within the device, e.g., to cause specific warpings to occur, which can be used to cause the device to be deformed into a particular shape or configuration.
  • a “line” of such mismatches can be used to cause an intentional bending or folding along the line of the device.
  • the device may include one or more electrical elements, for example, in a first component of the device, which may be the same or different from each other, in accordance with various aspects.
  • at least one of the electrical elements are electrodes.
  • the electrical elements are nanoscale electrical elements, such as nanoscale wires, and/or microscale electrical elements, such as microscale wires.
  • Non-limiting examples of such electrical elements are discussed in detail herein, and include, for instance, semiconductor wires (e.g., semiconductor nanowires or microwires), carbon nanotubes or microtubes, carbon fibers, organic electrical elements, or the like.
  • at least one of the electrical elements is a silicon nanowire.
  • the electrical elements may also be straight, or kinked in some cases.
  • one or more of the electrical elements may form at least a portion of a transistor, such as a field-effect transistor, e.g., as is discussed in more detail herein.
  • the electrical elements may be distributed within the device in any suitable configuration, for example, in an ordered array or randomly distributed. In some cases, the electrical elements are distributed such that an increasing concentration of electrical elements can be found towards the first component of the device.
  • At least one of the electrical elements has a diameter of less than about 100 micrometers.
  • the electrical elements may have a diameter of less than or equal to 800 micrometers, less than or equal to 600 micrometers, less than or equal to 400 micrometers, less than or equal to 200 micrometers, less than or equal to 100 micrometers, less than or equal to 80 micrometers, less than or equal to 60 micrometers, less than or equal to 40 micrometers, less than or equal to 20 micrometers, less than or equal to 10 micrometers, less than or equal to 5 micrometers, less than or equal to 1 micrometer, etc.
  • some or all of the electrical elements are individually electrically addressable within the device. For instance, in some cases, at least about 10%, at least about 20%, at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 80%, at least about 90%, or substantially all of the electrical elements may be individually electrically addressable.
  • an electrical property of electrical elements can be individually determinable (e.g., being partially or fully resolvable without also including the electrical properties of other electrical elements), and/or such that the electrical property of an electrical element may be individually controlled (for example, by applying a desired voltage or current to the electrical element, for instance, without simultaneously applying the voltage or current to other electrical elements).
  • at least some of the electrical elements can be controlled within the same electronic circuit (e.g., by incorporating the electrical elements in series and/or in parallel), such that the electrical elements can still be electrically controlled and/or determined.
  • more than one electrical element may be present within the device.
  • the electrical elements may each independently be the same or different.
  • the device may comprise at least 5 electrical elements, at least about 10 electrical elements, at least about 15 electrical elements, at least about 20 electrical elements, at least about 25 electrical elements, at least about 30 electrical elements, at least about 50 electrical elements, at least about 100 electrical elements, at least about 300 electrical elements, at least about 1000 electrical elements, etc.
  • the electrical elements may be distributed uniformly or non-uniformly on the device or a portion thereof, e.g., a first component.
  • the electrical elements may be distributed at an average density of at least 1 elements/mm 2 , at least 2 elements/mm 2 , at least 3 elements/mm 2 , about 5 elements/mm 2 , at least about 10 elements/mm 2 , at least about 30 elements/mm 2 , at least about 50 elements/mm 2 , at least about 75 elements/mm 2 , at least about 100 elements/mm 2 , at least about 300 elements/mm 2 , at least about 500 elements/mm 2 , at least about 750 elements/mm 2 , at least about 1000 elements/mm 2 , etc.
  • the electrical elements are distributed such that the average separation between an electrical element and its nearest neighboring electrical element is less than about 2 mm, less than about 1 mm, less than about 500 micrometers, less than about 300 micrometers, less than about 100 micrometers, less than about 50 micrometers, less than about 30 micrometers, or less than about 10 micrometers.
  • the electrical elements may be in electrical communication with one or more electrical contacts (e.g., in a second component of the device) via one or more conductive pathways (e.g., passing through a joining component, if present).
  • the electrical contacts may be positioned on a second component of the device that is not inserted into the blood vessel of a subject.
  • the electrical contacts may be made out of any suitable material that allows transmission of an electrical signal.
  • the electrical contacts may comprise gold, silver, copper, aluminum, tantalum, titanium, nickel, tungsten, chromium, palladium, platinum, etc.
  • the electrical contacts have an average cross-section of less than about 10 micrometers, less than about 8 micrometers, less than about 6 micrometers, less than about 5 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1 micrometer, etc.
  • the electrical contacts can be used to determine a property of an electrical element within the device (for example, an electrical property or a chemical property as is discussed herein), and/or to direct an electrical signal to the electrical element, e.g., to electrically stimulate cells proximate the electrical element.
  • the conductive pathways can form an electrical circuit that is internally contained within the device, and/or that extends externally of the device, e.g., such that the electrical circuit is in electrical communication with an external electrical system, such as a computer or a transmitter (for instance, a radio transmitter, a wireless transmitter, an Internet connection, etc.), as discussed herein. Any suitable conductive pathway may be used, for example, pathways comprising metals, semiconductors, conductive polymers, or the like.
  • more than one conductive pathway may be used in certain embodiments.
  • multiple conductive pathways can be used such that some or all of the electrical elements within the device may be electrically individually addressable.
  • more than one electrical element may be addressable by a particular conductive pathway.
  • other electric components may also be present within the device, e.g., as part of a conductive pathway or otherwise forming part of an electrical circuit. Examples include, but are not limited to, transistors such as fieldeffect transistors or bipolar junction transistors, resistors, capacitors, inductors, diodes, integrated circuits, etc. In certain cases, some of these may also comprise nanoscale wires and/or microscale wires.
  • two sets of electrical contacts and conductive pathways, and an electrical element such as a nanoscale wire may be used to define a transistor such as a field effect transistor, e.g., where the nanoscale wire or other electrical element defines the gate.
  • a transistor such as a field effect transistor
  • the environment in and/or around the electrical element can affect the ability of the electrical element to function as a gate, and thus, the electrical element can be used as a sensor in some embodiments.
  • one or more electrodes, electrical connectors, and/or conductive pathways may be positioned in electrical and/or physical communication with the electrical elements. These can be patterned to be in direct physical contact the electrical elements and/or there may be other materials that allow electrical communication to occur.
  • Metals may be used due to their high conductance, e.g., such that changes within electrical properties obtained from the conductive pathway may be related to changes in properties of the electrical elements, rather than changes in properties of the conductive pathway.
  • other types of electrode materials are used, in addition or instead of metals.
  • metals may be used in various embodiments, for example in an electrode, electrical connector, conductive pathway, metal construct, polymer construct, etc.
  • the metals may include one or more of aluminum, gold, silver, copper, molybdenum, tantalum, titanium, nickel, tungsten, chromium, palladium, platinum, as well as any combinations of these and/or other metals.
  • the electrode may comprise platinum.
  • the metal may be chosen to be one that is readily introduced, e.g., using techniques compatible with lithographic techniques.
  • lithographic techniques such as e-beam lithography, photolithography, X-ray lithography, extreme ultraviolet lithography, ion projection lithography, etc. can be used to pattern or deposit one or more metals.
  • the thickness of one of these may be less than about 1 mm, less than about 500 micrometers, less than about 300 micrometers, less than about 200 micrometers, less than about 100 micrometers, less than about 50 micrometers, less than about 30 micrometers, less than about 20 micrometers, less than about 10 micrometers, less than about 5 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1 micrometer, less than about 700 nm, less than about 600 nm, less than about 500 nm, less than about 300 nm, less than about 200 nm, less than about 100 nm, less than about 80 nm, less than about 50 nm, less than about 30 nm, less than about 1 mm, less than about 500 micrometers, less than about 300 nm, less than about 200 nm, less than about 100 nm, less than about 80 nm, less than about 50 nm, less than about 30 nm, less
  • the thickness of the electrode may also be at least about 10 nm, at least about 20 nm, at least about 40 nm, at least about 60 nm, at least about 80 nm, or at least about 100 nm.
  • the thickness may be between about 40 nm and about 100 nm, between about 50 nm and about 80 nm.
  • more than one metal may be used.
  • the metals can be deposited in different regions or alloyed together, or in some cases, the metals may be layered on top of each other, e.g., layered on top of each other using various lithographic techniques.
  • a second metal may be deposited on a first metal, and in some cases, a third metal may be deposited on the second metal, etc.
  • Additional layers of metal e.g., fourth, fifth, sixth, etc.
  • the metals may all be different, or in some cases, some of the metals (e.g., the first and third metals) may be the same.
  • Each layer may independently be of any suitable thickness or dimension, e.g., of the dimensions described above, and the thicknesses of the various layers may independently be the same or different.
  • a plurality of electrical elements comprises a plurality of sensing elements.
  • the electrical elements may include nanoscale wires. Any nanoscale wire can be used in the device, e.g., as a nanoscale sensing element.
  • suitable nanoscale wires include carbon nanotubes, nanorods, nanowires, organic and inorganic conductive and semiconducting polymers, metal nanoscale wires, semiconductor nanoscale wires (for example, formed from silicon), and the like. If carbon nanotubes are used, they may be single-walled and/or multi-walled, and may be metallic and/or semiconducting in nature.
  • conductive or semiconducting elements that may not be nanoscale wires, but are of various small nanoscopic-scale dimension, also can be used in certain embodiments. However, it should be understood that in some cases, larger electrical elements may also be used, e.g., microscale wires, in addition to or instead of nanoscale wires.
  • a “nanoscale wire” (also known herein as a “nanoscopic-scale wire” or “nanoscopic wire”) generally is a wire or other nanoscale object, that at any point along its length, has at least one cross-sectional dimension and, in some embodiments, two orthogonal cross-sectional dimensions (e.g., a diameter) of less than 1 micrometer, less than about 500 nm, less than about 200 nm, less than about 150 nm, less than about 100 nm, less than about 70, less than about 50 nm, less than about 20 nm, less than about 10 nm, less than about 5 nm, than about 2 nm, or less than about 1 nm.
  • microscale wires may be used, e.g., in addition to and/or instead of nanoscale wires.
  • a “microscale wire” is a wire or other microscale object that is larger than a nanoscale wire, and that at any point along its length, has at least one cross-sectional dimension and, in some embodiments, two orthogonal cross-sectional dimensions (e.g., a diameter) of less than 1 mm, less than 500 micrometers, less than about 200 micrometers, less than about 150 micrometers, less than about 100 micrometers, less than about 70, less than about 50 micrometers, less than about 20 micrometers, less than about 10 micrometers, less than about 5 micrometers, or than about 2 micrometers.
  • the nanoscale or microscale wire is generally cylindrical. In other embodiments, however, other shapes are possible; for example, the nanoscale wire or microscale wire can be faceted, i.e., the nanoscale wire or microscale wire may have a polygonal cross-section.
  • the cross-section of a nanoscale wire or microscale wire can be of any arbitrary shape, including, but not limited to, circular, square, rectangular, annular, polygonal, or elliptical, and may be a regular or an irregular shape.
  • the nanoscale wire or microscale wire can also be solid or hollow.
  • the nanoscale wire or microscale wire has one dimension that is substantially longer than the other dimensions of the nanoscale wire or microscale wire.
  • the nanoscale wire or microscale wire may have a longest dimension that is at least about 1 micrometer, at least about 3 micrometers, at least about 5 micrometers, or at least about 10 micrometers or about 20 micrometers in length, and/or the nanoscale wire or microscale wire may have an aspect ratio (longest dimension to shortest orthogonal dimension) of greater than about 2:1, greater than about 3:1, greater than about 4:1, greater than about 5:1, greater than about 10:1, greater than about 25:1, greater than about 50:1, greater than about 75:1, greater than about 100:1, greater than about 150:1, greater than about 250:1, greater than about 500:1, greater than about 750:1, or greater than about 1000:1 or more in some cases.
  • a nanoscale wire or microscale wire may be substantially uniform, or have a variation in average diameter of the nanoscale wire or microscale wire of less than about 30%, less than about 25%, less than about 20%, less than about 15%, less than about 10%, or less than about 5%.
  • the nanoscale wire or microscale wire may be grown from substantially uniform nanoclusters or particles, e.g., colloid particles. See, e.g., U.S. Patent No. 7,301,199, issued November 27, 2007, entitled “Nanoscale Wires and Related Devices,” by Lieber, et al., incorporated herein by reference in its entirety.
  • the nanoscale wire or microscale wire may be one of a population of nanoscale wires or microscale wires having an average variation in diameter, of the population of nanoscale or microscale wires, of less than about 30%, less than about 25%, less than about 20%, less than about 15%, less than about 10%, or less than about 5%.
  • a nanoscale wire or microscale wire has a conductivity of or of similar magnitude to any semiconductor or any metal.
  • the nanoscale wire or microscale wire can be formed of suitable materials, e.g., semiconductors, metals, etc., as well as any suitable combinations thereof.
  • the nanoscale wire or microscale wire will have the ability to pass electrical charge, for example, being electrically conductive.
  • the nanoscale wire may have a relatively low resistivity, e.g., less than about 10’ 3 Ohm m, less than about 10’ 4 Ohm m, less than about 10’ 6 Ohm m, or less than about 10’ 7 Ohm m.
  • the nanoscale wire or microscale wire can, in some embodiments, have a conductance of at least about 10 nanosiemens, at least about 30 nanosiemens, at least about 50 nanosiemens, at least about 100 nanosiemens, at least about 300 nanosiemens, at least about 500 nanosiemens, at least about 1 microsiemens, at least about 3 microsiemens, at least about 10 microsiemens, at least about 30 microsiemens, or at least about 100 microsiemens.
  • nanoscale wire or microscale wire can be solid or hollow, in various embodiments.
  • a “nanotube” is a nanoscale wire (or a microscale wire) that is hollow, or that has a hollowed-out core, including those nanotubes or microtubes known to those of ordinary skill in the art.
  • a nanotube or microtube may be created by creating a core/shell nanowire or microwire, then etching away at least a portion of the core to leave behind a hollow shell.
  • the nanoscale wire is a non-carbon nanotube.
  • a “nanowire” is a nanoscale wire (or a microscale wire) that is typically solid (i.e., not hollow).
  • a nanoscale wire may be a semiconductor nanowire, such as a silicon nanowire.
  • a nanoscale wire or microscale wire may comprise or consist essentially of a metal.
  • metals include aluminum, gold, silver, copper, molybdenum, tantalum, titanium, nickel, tungsten, chromium, or palladium.
  • a nanoscale wire or microscale wire comprises or consists essentially of a semiconductor.
  • a semiconductor is an element having semiconductive or semi-metallic properties (i.e., between metallic and non-metallic properties).
  • An example of a semiconductor is silicon.
  • Other non-limiting examples include elemental semiconductors, such as gallium, germanium, diamond (carbon), tin, selenium, tellurium, boron, or phosphorous.
  • more than one element may be present in the nanoscale wire as the semiconductor, for example, gallium arsenide, gallium nitride, indium phosphide, cadmium selenide, etc.
  • Still other examples include a Group II- VI material (which includes at least one member from Group II of the Periodic Table and at least one member from Group VI, for example, ZnS, ZnSe, ZnSSe, ZnCdS, CdS, or CdSe), or a Group III-V material (which includes at least one member from Group III and at least one member from Group V, for example GaAs, GaP, GaAsP, InAs, InP, AlGaAs, or InAsP).
  • at least one of the nanoscale wires is a silicon nanowire.
  • the semiconductor can be undoped or doped (e.g., p-type or n-type).
  • a nanoscale wire or a microscale wire may be a p-type semiconductor nanoscale wire or an n-type semiconductor wire, and can be used as a component of a transistor such as a field effect transistor (“FET”).
  • FET field effect transistor
  • the nanoscale wire or microscale wire may act as the “gate” of a source-gate-drain arrangement of a FET, while metal leads or other conductive pathways (as discussed herein) are used as the source and drain electrodes.
  • a dopant or a semiconductor may include mixtures of Group IV elements, for example, a mixture of silicon and carbon, or a mixture of silicon and germanium.
  • the dopant or the semiconductor may include a mixture of a Group III and a Group V element, for example, BN, BP, BAs, AIN, A1P, AlAs, AlSb, GaN, GaP, GaAs, GaSb, InN, InP, InAs, or InSb. Mixtures of these may also be used, for example, a mixture of BN/BP/BAs, or BN/A1P.
  • the dopants may include alloys of Group III and Group V elements.
  • the alloys may include a mixture of AlGaN, GaPAs, InPAs, GalnN, AlGalnN, GalnAsP, or the like.
  • the dopants may also include a mixture of Group II and Group VI semiconductors.
  • the semiconductor may include ZnO, ZnS, ZnSe, ZnTe, CdS, CdSe, CdTe, HgS, HgSe, HgTe, BeS, BeSe, BeTe, MgS, MgSe, or the like. Alloys or mixtures of these dopants are also possible, for example, (ZnCd)Se, or Zn(SSe), or the like.
  • alloys of different groups of semiconductors may also be possible, for example, a combination of a Group II-Group VI and a Group III-Group V semiconductor, for example, (GaAs) x (ZnS)i-x.
  • dopants may include combinations of Group IV and Group VI elements, such as GeS, GeSe, GeTe, SnS, SnSe, SnTe, PbO, PbS, PbSe, or PbTe.
  • Other semiconductor mixtures may include a combination of a Group I and a Group VII, such as CuF, CuCl, CuBr, Cui, AgF, AgCl, AgBr, Agl, or the like.
  • dopant compounds may include different mixtures of these elements, such as BeSiN2, CaCN2, ZnGeP2, CdSnAs2, ZnSnSb 2 , CuGeP 3 , CuSi 2 P 3 , Si 3 N 4 , Ge 3 N 4 , A1 2 O 3 , (Al, Ga, In) 2 (S, Se, Te) 3 , A1 2 CO, (Cu, Ag)(Al, Ga, In, Tl, Fe)(S, Se, Te)2 and the like.
  • BeSiN2, CaCN2, ZnGeP2, CdSnAs2, ZnSnSb 2 CuGeP 3 , CuSi 2 P 3 , Si 3 N 4 , Ge 3 N 4 , A1 2 O 3 , (Al, Ga, In) 2 (S, Se, Te) 3 , A1 2 CO, (Cu, Ag)(Al, Ga, In, Tl, Fe)(S, Se, Te)2 and the like.
  • the doping of the semiconductor to produce a p-type or n-type semiconductor may be achieved via bulk-doping in certain embodiments, although in other embodiments, other doping techniques (such as ion implantation) can be used. Many such doping techniques that can be used will be familiar to those of ordinary skill in the art, including both bulk doping and surface doping techniques.
  • a bulk-doped article e.g. an article, or a section or region of an article
  • one or more regions comprise a single monolayer of atoms (“deltadoping”). In certain cases, the region may be less than a single monolayer thick (for example, if some of the atoms within the monolayer are absent). As a specific example, the regions may be arranged in a layered structure within the nanoscale wire, and one or more of the regions can be delta-doped or partially delta-doped.
  • the nanoscale wire or microscale wire may include a heterojunction, e.g., of two regions with dissimilar materials or elements, and/or the same materials or elements but at different ratios or concentrations.
  • the regions of the wire may be distinct from each other with minimal cross-contamination, or the composition of the nanoscale wire can vary gradually from one region to the next.
  • the regions may be both longitudinally arranged relative to each other, or radially arranged (e.g., as in a core/shell arrangement) on the wire. Each region may be of any size or shape within the wire.
  • the junctions may be, for example, a p/n junction, a p/p junction, an n/n junction, a p/i junction (where i refers to an intrinsic semiconductor), an n/i junction, an i/i junction, or the like.
  • the junction can also be a Schottky junction in some embodiments.
  • the junction may also be, for example, a semiconductor/semiconductor junction, a semiconductor/metal junction, a semiconductor/insulator junction, a metal/metal junction, a metal/insulator junction, an insulator/insulator junction, or the like.
  • the junction may also be a junction of two materials, a doped semiconductor to a doped or an undoped semiconductor, or a junction between regions having different dopant concentrations.
  • the junction can also be a defected region to a perfect single crystal, an amorphous region to a crystal, a crystal to another crystal, an amorphous region to another amorphous region, a defected region to another defected region, an amorphous region to a defected region, or the like. More than two regions may be present, and these regions may have unique compositions or may comprise the same compositions.
  • a wire can have a first region having a first composition, a second region having a second composition, and a third region having a third composition or the same composition as the first composition.
  • nanoscale wires comprising heterojunctions (including core/shell heterojunctions, longitudinal heterojunctions, etc., as well as combinations thereof) are discussed in U.S. Patent No. 7,301,199, issued November 27, 2007, entitled “Nanoscale Wires and Related Devices,” by Lieber, et al., incorporated herein by reference in its entirety.
  • the nanoscale wire or microscale wire is formed from a single crystal, for example, a single crystal nanoscale wire comprising a semiconductor.
  • a single crystal item may be formed via covalent bonding, ionic bonding, or the like, and/or combinations thereof. While such a single crystal item may include defects in the crystal in some cases, the single crystal item is distinguished from an item that includes one or more crystals, not ionically or covalently bonded, but merely in close proximity to one another.
  • the nanoscale wires or microscale wires used herein are individual or free-standing nanoscale wires.
  • an “individual” or a “freestanding” wire may, at some point in its life, not be attached to another article, for example, with another wire, or the free-standing wire may be in solution.
  • This is in contrast to nanoscale features etched onto the surface of a substrate, e.g., a silicon wafer, in which the nanoscale features are never removed from the surface of the substrate as a free-standing article.
  • An “individual” or a “free-standing” wire is one that can be (but need not be) removed from the location where it is made, as an individual article, and transported to a different location and combined with different components to make a functional device such as those described herein.
  • the nanoscale wire or microscale wire may be a sensing element responsive to a property external of the wire, e.g., a chemical property, an electrical property, a physical property, etc. Such determination may be qualitative and/or quantitative, and such determinations may also be recorded, e.g., for later use.
  • the wire may be responsive to voltage.
  • the nanoscale wire or microscale wire may exhibit a voltage sensitivity of at least about 5 microsiemens/V; by determining the conductivity of a nanoscale wire, the voltage surrounding the wire may thus be determined.
  • the voltage sensitivity can be at least about 10 nanosiemens/V, at least about 30 nanosiemens/V, at least about 50 nanosiemens/V, at least about 100 nanosiemens/V, at least about 300 nanosiemens/V, at least about 500 nanosiemens/V, at least about 1 microsiemens/V, at least about 3 microsiemens/V, at least about 5 microsiemens/V, at least about 10 microsiemens/V, at least about 30 microsiemens/V, at least about 50 microsiemens/V, or at least about 100 microsiemens/V.
  • Other examples of electrical properties that can be determined include resistance, resistivity, conductance, conductivity, impendence, or the like.
  • a nanoscale wire or microscale wire may be a sensing element responsive to a chemical property of the environment surrounding the wire.
  • an electrical property of the wire can be affected by a chemical environment surrounding the wire, and the electrical property can be thereby determined to determine the chemical environment surrounding the nanoscale wire.
  • a nanoscale wire or microscale wire may be sensitive to pH or hydrogen ions. Further nonlimiting examples of such wires are discussed in U.S. Patent No. 7,129,554, filed October 31, 2006, entitled “Nanosensors,” by Lieber, et al., incorporated herein by reference in its entirety.
  • the nanoscale wire or microscale wire may be a sensing element having the ability to bind to an analyte indicative of a chemical property of the environment surrounding the nanoscale wire or microscale wire (e.g., hydrogen ions for pH, or concentration for an analyte of interest), and/or the wire may be partially or fully functionalized, i.e. comprising surface functional moieties, to which an analyte is able to bind, thereby causing a determinable property change to the nanoscale wire or microscale wire, e.g., a change to the resistivity or impedance of the wire.
  • the binding of the analyte can be specific or non-specific.
  • Functional moieties may include simple groups, selected from the groups including, but not limited to, -OH, -CHO, -COOH, -SO3H, -CN, -NH2, -SH, -COSH, -COOR, halide; biomolecular entities including, but not limited to, amino acids, proteins, sugars, DNA, antibodies, antigens, and enzymes; grafted polymer chains with chain length less than the diameter of the wire, selected from a group of polymers including, but not limited to, polyamide, polyester, polyimide, polyacrylic; a shell of material comprising, for example, metals, semiconductors, and insulators, which may be a metallic element, an oxide, an sulfide, a nitride, a selenide, a polymer and a polymer gel.
  • PSA prote specific antigen
  • a non-limiting example of a protein is PSA (prostate specific antigen), which can be determined, for example, by modifying the wires by binding monoclonal antibodies for PSA (Abl) thereto. See, e.g., U.S. Pat. No. 8,232,584, issued July 31, 2012, entitled “Nanoscale Sensors,” by Lieber, et al., incorporated herein by reference in its entirety.
  • a reaction entity may be bound to a surface of the nanoscale wire or microscale wire, and/or positioned in relation to the wire such that the analyte can be determined by determining a change in a property of the nanoscale wire or microscale wire, e.g., acting as a sensing element.
  • the “determination” may be quantitative and/or qualitative, depending on the application, and in some cases, the determination may also be analyzed, recorded for later use, transmitted, or the like.
  • reaction entity refers to any entity that can interact with an analyte in such a manner to cause a detectable change in a property (such as an electrical property) of a nanoscale wire or microscale wire.
  • the reaction entity may enhance the interaction between the wire and the analyte, or generate a new chemical species that has a higher affinity to the wire, or to enrich the analyte around the wire.
  • the reaction entity can comprise a binding partner to which the analyte binds.
  • the reaction entity when a binding partner, can comprise a specific binding partner of the analyte.
  • the reaction entity may be a nucleic acid, an antibody, a sugar, a carbohydrate or a protein.
  • the reaction entity may be a polymer, catalyst, or a quantum dot.
  • a reaction entity that is a catalyst can catalyze a reaction involving the analyte, resulting in a product that causes a detectable change in the nanowire, e.g. via binding to an auxiliary binding partner of the product electrically coupled to the nanowire.
  • Another exemplary reaction entity is a reactant that reacts with the analyte, producing a product that can cause a detectable change in the wire.
  • the reaction entity can comprise a shell on the wire, e.g. a shell of a polymer that recognizes molecules in, e.g., a gaseous sample, causing a change in conductivity of the polymer which, in turn, causes a detectable change in the nanowire.
  • a property such as a chemical property and/or an electrical property can be determined by the electrical elements, e.g., at a resolution of less than about 2 mm, less than about 1 mm, less than about 500 micrometers, less than about 300 micrometers, less than about 100 micrometers, less than about 50 micrometers, less than about 30 micrometers, or less than about 10 micrometers, etc., e.g., due to the average separation between an electrical element (such as a nanoscale wire) and its nearest neighboring electrical element.
  • such properties can be determined and/or recorded as a function of time.
  • such properties can be determined at a time resolution of less than about 1 min, less than about 30 s, less than about 15 s, less than about 10 s, less than about 5 s, less than about 3 s, less than about 1 s, less than about 500 ms, less than about 300 ms, less than about 100 ms, less than about 50 ms, less than about 30 ms, less than about
  • a device can be constructed by assembling various polymers, metals, electrodes, nanoscale wires, microscale wires, and/or other components together on a substrate. Portions of the device (e.g., a first component, a second component, and/or a joining component, if present) may be fabricated using the same or different techniques, including any of the ones discussed herein, and thus may include the same or different materials. For example, lithographic techniques such as e-beam lithography, photolithography, X-ray lithography, extreme ultraviolet lithography, ion projection lithography, etc.
  • FIG. 11 A schematic diagram of the layers formed on the substrate in one embodiment is shown in FIG. 11 However, it should be understood that this diagram is illustrative only and is not drawn to scale, and not all of the layers shown in FIG.
  • the device can be used in non-living subjects.
  • the substrate (200 in FIG. 11) may be chosen to be one that can be used for lithographic techniques such as e-beam lithography or photolithography, or other lithographic techniques including those discussed herein.
  • the substrate may comprise or consist essentially of a semiconductor material such as silicon, although other substrate materials (e.g., a metal or glass, etc.) can also be used.
  • the substrate is one that is substantially planar, e.g., so that polymers, metals, and the like can be patterned on the substrate.
  • a portion of the substrate can be oxidized, e.g., forming SiO2 and/or SisN4 on a portion of the substrate, which may facilitate subsequent addition of materials (metals, polymers, etc.) to the substrate.
  • the oxidized portion may form a layer of material on the substrate (205 in Fig.
  • 11 e.g., having a thickness of less than about 5 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1 micrometer, less than about 900 nm, less than about 800 nm, less than about 700 nm, less than about 600 nm, less than about 500 nm, less than about 400 nm, less than about 300 nm, less than about 200 nm, less than about 100 nm, etc.
  • one or more polymers can also be deposited or otherwise formed prior to depositing the sacrificial material.
  • the polymers may be deposited or otherwise formed as a layer of material (210 in FIG. 11) on the substrate. Deposition may be performed using any suitable technique, e.g., using lithographic techniques such as e-beam lithography, photolithography, X-ray lithography, extreme ultraviolet lithography, ion projection lithography, etc.
  • some or all of the polymers may be biocompatible and/or biodegradable (e.g., polyacrylic acid).
  • the polymers that are deposited may also comprise methyl methacrylate and/or poly(methyl methacrylate), in some embodiments.
  • One, two, or more layers of polymer can be deposited (e.g., sequentially) in various embodiments, and each layer may independently have a thickness of less than about 5 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1 micrometer, less than about 900 nm, less than about 800 nm, less than about 700 nm, less than about 600 nm, less than about 500 nm, less than about 400 nm, less than about 300 nm, less than about 200 nm, less than about 100 nm, etc.
  • a sacrificial material may be deposited.
  • the sacrificial material can be chosen to be one that can be removed without substantially altering other materials (e.g., polymers, other metals, nanoscale wires, microscale wires, etc.) deposited thereon.
  • the sacrificial material may be a metal, e.g., one that is easily etchable.
  • the sacrificial material can comprise germanium or nickel, which can be etched or otherwise removed, for example, using a peroxide (e.g., H2O2) or a nickel etchant (many of which are readily available commercially).
  • the sacrificial material may be deposited on oxidized portions or polymers previously deposited on the substrate. In some cases, the sacrificial material is deposited as a layer (e.g., 215 in FIG. 11).
  • the layer can have a thickness of less than about 5 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1 micrometer, less than about 900 nm, less than about 800 nm, less than about 700 nm, less than about 600 nm, less than about 500 nm, less than about 400 nm, less than about 300 nm, less than about 200 nm, less than about 100 nm, etc.
  • a bottom layer comprising a “bedding” polymer can be deposited, e.g., on the sacrificial material.
  • a layer of guidewire (245a in FIG. 11) may be optionally disposed between the sacrificial material and bedding polymer.
  • the bedding polymer may include one or more polymers, which may be deposited as one or more layers (220 in FIG. 11).
  • the bedding polymer can be used to support the metal lead/interconnect (235 in FIG. 11), and partially or completely surround metal lead/interconnect, depending on the application.
  • the bedding polymer can be used to support, and partially or completely surround the nanoscale wires and/or microscale wires, depending on the application.
  • the bedding polymer can at least partially define a device.
  • the bedding polymer may be deposited as a layer of material, such that portions of the bedding polymer may be subsequently removed.
  • the bedding polymer can be deposited using lithographic techniques such as e-beam lithography, photolithography, X-ray lithography, extreme ultraviolet lithography, ion projection lithography, etc., or using other techniques for removing polymer that are known to those of ordinary skill in the art.
  • more than one bedding polymer is used, e.g., deposited as more than one layer (e.g., sequentially), and each layer may independently have a thickness of less than about 5 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1 micrometer, less than about 900 nm, less than about 800 nm, less than about 700 nm, less than about 600 nm, less than about 500 nm, less than about 400 nm, less than about 300 nm, less than about 200 nm, less than about 100 nm, etc.
  • portions of the photoresist may be exposed to light (visible, UV, etc.), electrons, ions, X-rays, etc. (e.g., projected onto the photoresist), and the exposed portions can be etched away (e.g., using suitable etchants, plasma, etc.) to produce the pattern.
  • light visible, UV, etc.
  • electrons, ions, X-rays, etc. e.g., projected onto the photoresist
  • the exposed portions can be etched away (e.g., using suitable etchants, plasma, etc.) to produce the pattern.
  • the bedding polymer may be formed into a particular pattern, e.g., in a grid, or in a pattern that suggests an endogenous probe, before or after deposition of metal lead/interconnect.
  • the pattern can be regular or irregular.
  • the bedding polymer can be formed into a pattern defining pore sizes such as those discussed herein.
  • the polymer may have an average pore size of at least about 50 micrometers, at least about 100 micrometers, at least about 200 micrometers, at least about 300 micrometers, at least about 400 micrometers, at least about 500 micrometers, at least about 600 micrometers, at least about 700 micrometers, at least about 800 micrometers, at least about 900 micrometers, or at least about 1 mm, and/or an average pore size of no more than about 1.5 mm, no more than about 1.4 mm, no more than about 1.3 mm, no more than about 1.2 mm, no more than about 1.1 mm, no more than about 1 mm, no more than about 900 micrometers, no more than about 800 micrometers, no more than about 700 micrometers, no more than about 600 micrometers, or no more than about 500 micrometers, etc.
  • any suitable polymer may be used as the bedding polymer.
  • one or more of the polymers can be chosen to be biocompatible and/or biodegradable.
  • one or more of the bedding polymers may comprise a negative photoresist.
  • Photoresists can be useful due to their familiarity in use in lithographic techniques such as those discussed herein. Non-limiting examples of photoresists include SU-8, AZ 15nXT, AZ 125 nXT, AZ nLOF 2000 Series, KMPR, UVN-30, ma-N 1400 Series, ma-N 2400 Series, etc., as well as any others discussed herein.
  • materials other than photoresists may also be used.
  • etching methods such as reactive ion etching may be used to form the bedding polymer.
  • any suitable polymers e.g., polyimide capable of being etched may be used.
  • one or more of the bedding polymers can be heated or baked, e.g., before or after depositing the metal lead/interconnect thereon as discussed below, and/or before or after patterning the bedding polymer.
  • heating or baking in some cases, is important to prepare the polymer for lithographic patterning.
  • the bedding polymer may be heated to a temperature of at least about 30 °C, at least about 65 °C, at least about 95 °C, at least about 150 °C, or at least about 180 °C, etc.
  • one or more nanoscale wires and/or microscale wires may be deposited, e.g., on a bedding polymer on the substrate prior to deposition of the metal layer.
  • Any of the nanoscale wires and/or microscale wires described herein may be used, e.g., n-type and/or p- type wires, substantially uniform wires (e.g., having a variation in average diameter of less than 20%), nanoscale wires having a diameter of less than about 1 micrometer, semiconductor wires, silicon nanowires, bent wires, kinked wires, core/shell wires, nanoscale or microscale wires with heterojunctions, etc.
  • the nanoscale wires and/or microscale wires are present in a liquid which is applied to the substrate, e.g., poured, painted, or otherwise deposited thereon.
  • the liquid is chosen to be relatively volatile, such that some or all of the liquid can be removed by allowing it to substantially evaporate, thereby depositing the nanoscale wires and/or microscale wires.
  • at least a portion of the liquid can be dried off, e.g., by applying heat to the liquid. Examples of suitable liquids include water or isopropanol.
  • a metal or other conductive material can be deposited (235 in FIG. 11) to form a metal lead and/or other conductive pathway.
  • More than one metal can be used, which may be deposited as one or more layers.
  • a first metal may be deposited, e.g., on one or more of the lead polymers, and a second metal may be deposited on at least a portion of the first metal.
  • more metals can be used, e.g., a third metal may be deposited on at least a portion of the second metal, and the third metal may be the same or different from the first metal.
  • each metal may independently have a thickness of less than about 5 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1 micrometer, less than about 900 nm, less than about 800 nm, less than about 700 nm, less than about 600 nm, less than about 500 nm, less than about 400 nm, less than about 300 nm, less than about 200 nm, less than about 100 nm, less than about 80 nm, less than about 60 nm, less than about 40 nm, less than about 30 nm, less than about 20 nm, less than about 10 nm, less than about 8 nm, less than about 6 nm, less than about 4 nm, or less than about 2 nm, etc., and the layers may be of the same or different thicknesses.
  • deposition techniques such as sputtering can be used.
  • Other examples include, but are not limited to, physical vapor deposition, vacuum deposition, chemical vapor deposition, cathodic arc deposition, evaporative deposition, e-beam PVD, pulsed laser deposition, ion-beam sputtering, reactive sputtering, ion-assisted deposition, high-target-utilization sputtering, high-power impulse magnetron sputtering, gas flow sputtering, or the like.
  • the metals can be chosen in some cases such that the deposition process yields a prestressed arrangement, e.g., due to atomic lattice mismatch, which causes the subsequent metal leads to warp or bend, for example, once released from the substrate.
  • a prestressed arrangement e.g., due to atomic lattice mismatch, which causes the subsequent metal leads to warp or bend, for example, once released from the substrate.
  • pre-stressed arrangements may be used to cause the resulting device to form a 3-dimensional structure, in some cases spontaneously, upon release from the substrate.
  • the metals may not necessary be deposited in a prestressed arrangement.
  • metals that can be deposited include, but are not limited to, aluminum, gold, silver, copper, molybdenum, tantalum, titanium, nickel, tungsten, chromium, palladium, platinum, as well as any combinations of these and/or other metals.
  • a chromium/palladium/chromium deposition process in some embodiments, may form a pre-stressed arrangement that is able to spontaneously form a 3-dimensional structure after release from the substrate.
  • a top layer comprising a “coating” polymer can be deposited (240 in FIG. 11), e.g., on at least some of the conductive pathways.
  • the coating polymer may include one or more polymers, which may be deposited as one or more layers.
  • the coating polymer may be deposited on one or more portions of a substrate, e.g., as a layer of material such that portions of the coating polymer can be subsequently removed, e.g., using lithographic techniques such as e-beam lithography, photolithography, X-ray lithography, extreme ultraviolet lithography, ion projection lithography, etc., or using other techniques for removing polymer that are known to those of ordinary skill in the art, similar to the other polymers previously discussed.
  • the coating polymers can be the same or different from the lead polymers and/or the bedding polymers.
  • more than one coating polymer may be used, e.g., deposited as more than one layer (e.g., sequentially), and each layer may independently have a thickness of less than about 5 micrometers, less than about 4 micrometers, less than about 3 micrometers, less than about 2 micrometers, less than about 1 micrometer, less than about 900 nm, less than about 800 nm, less than about 700 nm, less than about 600 nm, less than about 500 nm, less than about 400 nm, less than about 300 nm, less than about 200 nm, less than about 100 nm, etc.
  • any suitable polymer may be used as the coating polymer.
  • one or more of the polymers can be chosen to be biocompatible and/or biodegradable.
  • one or more of the polymers may comprise poly(methyl methacrylate).
  • one or more of the coating polymers may comprise a photoresist, e.g., as discussed herein.
  • one or more of the coating polymers can be heated or baked, e.g., before or after depositing nanoscale wires and/or microscale wires thereon as discussed below, and/or before or after patterning the coating polymer.
  • heating or baking in some cases, is important to prepare the polymer for lithographic patterning.
  • the coating polymer may be heated to a temperature of at least about 30 °C, at least about 65 °C, at least about 95 °C, at least about 150 °C, or at least about 180 °C, etc.
  • pre-made electrical elements e.g., electrodes
  • the metal lead e.g., 235 in FIG. 11
  • the metal lead or interconnect may directly physically contact the electrical elements and/or there may be other materials between the metal lead and the electrical elements that allow electrical communication to occur.
  • the electrical elements may be positioned in the layered structure (e.g., as shown in FIG.
  • each of the electrical elements may be in fluidic communication with an external environment, e.g., to sense an analyte in or to stimulate a response from the external environment (e.g., blood vessel).
  • the electrical element may be an electrode, e.g., such as single-sided electrode or double-sided electrode.
  • single-sided electrodes may be deposited together with the metal lead or in/on an adjacent layer, e.g., as long as the electrode can establish electrical communication with the metal lead.
  • a portion of the single-sided electrodes may be exposed on one side of the layered structure to an external environment in a subject.
  • double-sided electrodes may be deposited in the layered structure in FIG.
  • the electrodes in electrical communication with the metal lead and the electrodes to be in fluidic communication with an external environment on both sides of the layered structure, e.g., to sense an analyte or detect a response from the external environment.
  • a guide wire layer (e.g., 245b in FIG. 11) may be deposited on the coating polymer (e.g., 240 in FIG. 11), as disclosed previously with respect to FIG. 10. It should be noted that the bedding polymer 220, metal layer 235, and coating polymer 240 may have the same properties as the layers disclosed in FIG. 10.
  • the sacrificial material may then be removed in some cases.
  • at least a portion of the sacrificial material is exposed to an etchant able to remove the sacrificial material.
  • an etchant able to remove the sacrificial material.
  • the sacrificial material is a metal such as nickel
  • a suitable etchant for example, a metal etchant such as a nickel etchant, etc.
  • the device can also be dried, e.g., in air (e.g., passively), by using a heat source, by using a critical point dryer, etc.
  • the device upon removal of the sacrificial material, pre- stressed portions of the device (e.g., metal leads containing dissimilar metals) can spontaneously cause the device to adopt a 3-dimensional structure.
  • the device may form a 3- dimensional structure as discussed herein.
  • the device may have an open porosity of at least about 30%, at least about 40%, at least about 50%, at least about 60%, at least about 70%, at least about 75%, at least about 80%, at least about 85%, at least about 90%, at least about 95%, at least about 97, at least about 99%, at least about 99.5%, or at least about 99.8%.
  • the device may also have, in some cases, an average pore size of at least about 100 micrometers, at least about 200 micrometers, at least about 300 micrometers, at least about 400 micrometers, at least about 500 micrometers, at least about 600 micrometers, at least about 700 micrometers, at least about 800 micrometers, at least about 900 micrometers, or at least about 1 mm, and/or an average pore size of no more than about 1.5 mm, no more than about 1.4 mm, no more than about 1.3 mm, no more than about 1.2 mm, no more than about 1.1 mm, no more than about 1 mm, no more than about 900 micrometers, no more than about 800 micrometers, no more than about 700 micrometers, no more than about 600 micrometers, or no more than about 500 micrometers, etc.
  • the device may need to be rolled, curled, folded, creased, etc., or otherwise manipulated to form the 3 -dimensional structure.
  • Such manipulations can be done using any suitable technique, e.g., manually, or using a machine.
  • the device after insertion into matter, is able to expand, unroll, uncurl, etc., at least partially, e.g., due to the shape or structure of the device.
  • a mesh device may be able to expand after leaving the catheter.
  • Other materials may be also added to the device, e.g., before or after it forms a 3- dimensional structure, for example, to help stabilize the structure, to add additional agents to enhance its biocompatibility (e.g., growth hormones, extracellular matrix protein, MatrigelTM, etc.), to cause it to form a suitable 3-dimension structure, to control pore sizes, etc.
  • additional agents to enhance its biocompatibility e.g., growth hormones, extracellular matrix protein, MatrigelTM, etc.
  • growth hormones include other polymers, growth hormones, extracellular matrix protein, specific metabolites or nutrients, additional device materials, or the like. Many such growth hormones are commercially available, and may be readily selected by those of ordinary skill in the art based on the specific type of cell or tissue used or desired.
  • extracellular matrix proteins include gelatin, laminin, fibronectin, heparan sulfate, proteoglycans, entactin, hyaluronic acid, collagen, elastin, chondroitin sulfate, keratan sulfate, MatrigelTM, or the like. Many such extracellular matrix proteins are available commercially, and also can be readily identified by those of ordinary skill in the art based on the specific type of cell or tissue used or desired.
  • the device can be interfaced in some embodiments with one or more electronics, e.g., an external electrical device such as a computer or a transmitter (for instance, a radio transmitter, a wireless transmitter, etc.).
  • an external electrical device may be connected via one or more electrical contacts in the second component, for example.
  • electrical testing of the device may be performed, e.g., before or after introduction into a living or non-living subject.
  • one or more of the metal leads may be connected to an external electrical device, e.g., to electrically interrogate or otherwise determine the electronic state or one or more of the electrical elements (e.g., electrodes, nanoscale wires and/or microscale wires) within the device.
  • Such determinations may be performed quantitatively and/or qualitatively, depending on the application, and can involve all, or only a subset, of the electrical elements contained within the device, e.g., as discussed herein.
  • ultra-small and flexible endovascular neural probes can be implanted into small 100-micron scale blood vessels in deep brain regions of rats without damaging brain or vascular structures. Electrophysiology recording of local potential potentials and single-unit spikes has been selectively achieved in the cortex and the olfactory bulb. Chronic histology studies of the flexible electronics/vessel wall/brain tissue interface showed minimal immune response and long-term stability.
  • Mesh electronics with double-sided electrodes and input/output (I/O) metal regions were fabricated using standard photolithography.
  • a 100-nm-thick Ni sacrificial layer was thermally evaporated (Sharon Vacuum Co.) onto a 4-inch Si wafer (n-type 0.005 Ohm cm, 1,000 nm thermal oxide, NOVA Electronic Materials).
  • LOR 3 A and SI 805 (Microchem) were spin-coated at 4,000 rpm for 45 seconds and baked at 180 °C for 4 minutes and at 115 °C for 1 minute, respectively.
  • the photoresist was patterned by photolithography with a mask aligner (SUSS MA6 mask aligner, SUSS MicroTec) and developed (MF-CD-26, MicroChem Corp.) for 1 minute.
  • a 100-nm-thick Au bottom metal input/output (I/O) layer was deposited by thermal evaporation (Sharon Vacuum Co.), followed by a liftoff step (Remover PG, MicroChem).
  • the photolithography process in step 2 was repeated to define 80-micrometer Pt bottom electrode regions for E-beam evaporation (Denton Vacuum Co.), followed by a liftoff step.
  • negative photoresist SU- 8 (SU-8 2000.5; MicroChem) was spin-coated on the Si wafer at 3,000 rpm for 30 seconds, pre-baked at 65 °C for 1 minute and 95 °C for 1 minute, and then patterned by photolithography with the mask aligner. After post-baking at 65 °C for 1 minute and 95 °C for 1 minute, The SU-8 resist was developed in SU-8 developer (Microchem) for 1.5 minutes, rinsed with isopropanol, dried in N2 and hard baked at 185 °C for 1 hour.
  • step 2 The photolithography process in step 2 was repeated to define metal interconnects, followed by 100-nm-thick Au deposition by thermal evaporation and liftoff.
  • step 3 The process in step 3 was repeated to deposit the top layer of Pt electrodes.
  • negative photoresist SU-8 (SU-8 2010; MicroChem) was spin-coated on the Si wafer at 3,000 rpm for 30 seconds, pre -baked at 65 °C for 1 minute and 95 °C for 2 minutes, and then patterned by photolithography with the mask aligner.
  • a 5-ml syringe filled with sterile saline was attached to the 16-G needle and infused the PE-8 microcatheter with saline. The end of the tubing was position near the VO pads of the mesh electronics, the syringe was manually retracted to draw the mesh electronics into the microcatheter.
  • the 5-ml syringe was replaced with a 1-ml syringe filled with saline before implantation.
  • the degree of anesthesia was verified via toe pinch before surgery. Rectal temperature was maintained at 37.5 °C with a thermostat-controlled heating pad (EZ-TC-1000-M Homeothermic Temperature Controller). Puralube vet ointment (Dechra Pharmaceuticals) was applied on both eyes to prevent corneal damage. Hair removal lotion (Nair, Church & Dwight) was applied to the scalp for depilation and an alternating series of Betadine surgical scrub (Purdue Products) and 70% alcohol was applied to sterilize the depilated scalp skin. A sterile scalpel was used to make a 5 mm longitudinal incision in the scalp along the sagittal sinus. The scalp skin was resected to expose a 5 mmx5 mm portion of the skull.
  • a 1-mm-diameter burr hole was made using a dental drill (Micromotor with On/Off Pedal 110/220, Grobet USA) according to the following stereotaxic coordinates: anteroposterior, -3 mm; mediolateral, -3 mm.
  • a 3-cm long sterilized stainless steel wire (0.015 inches (0.381 cm), Malin Company) was bent and -0.5 mm at one end was inserted into this burr hole to serve as the grounding and reference electrode.
  • Metabond adhesive cement (Parkell) was applied to fix the wire/skull junction.
  • the ventral neck region was then depilated and sterilized.
  • the rat was placed under a dissection microscope (LEICA MZ75), and a pair of sterile scissors (Fine Science Tools) was used to make a 2 cm midline incision in the ventral neck region.
  • Retractors (Braintree Scientific) were used to separate the muscles and expose the right common carotid artery (CCA), external carotid artery (ECA), and internal carotid artery (ICA).
  • CCA right common carotid artery
  • ECA external carotid artery
  • ICA internal carotid artery
  • the arteries were then detached from surrounding tissues.
  • ECA the superior thyroid artery (STA) branch and occipital artery (OA) branch were coagulated with a bipolar coagulator (Kirwan Surgical Products), and cut at the coagulated segment.
  • STA superior thyroid artery
  • OA occipital artery
  • 4-0 silk sutures were used to ligate the ECA and temporarily stop blood flow in CCA and posterior auricular artery (PAA).
  • a vascular clamp (Fine Science Tools) was applied to ICA.
  • a small incision was then made at the distal end of the ECA stump with Vannas spring scissors (Fine Science Tools).
  • the microcatheter with loaded mesh electronics was inserted into the ECA stump (FIG. 1A).
  • a loose suture was placed on the ECA stump to prevent blood leakage around the microcatheter.
  • the vascular clamp on ICA was removed, and the microcatheter was inserted into ICA by 15-18 mm until reaching the bifurcation of middle cerebral artery (MCA) and ICA.
  • MCA middle cerebral artery
  • the mesh electronics were manually injected into the deeper branches by slowly pushing the plunger. The implantation depth is tracked by the location of the I/O pads in the microcatheter. The microcatheter was then retracted slowly (FIG. IB), additional injections were performed if the mesh was retracted together with the microcatheter. The ECA was then ligated with suture to fix the stem region of the mesh at the ECA opening (FIG. 1C). The vascular clamp and sutures on ICA, CCA and PAA were removed to allow reperfusion.
  • FIGs. 1A-1C illustrates mesh implantation procedures.
  • the microcatheter loaded with mesh electronics (not shown) was inserted into ECA stump and advanced to the MCA/ACA bifurcation (FIG. 1A).
  • a suture was placed around the ECA stump to prevent blood leakage around the microcatheter.
  • the microcatheter was retracted, leaving the mesh electronics inside, and fixed by tying the suture around the ECA stump (FIG. IB).
  • the microcatheter was pulled back to expose the mesh stem (FIG. 1C).
  • the mesh stem was cut at the ECA opening. Skin was closed by silk sutures.
  • FFC flat, flexible cables
  • WM11484-ND Digi-Key Electronics
  • Digi-Key Electronics were attached to a glass slide placed next to the rat’s neck.
  • the VO pads were aligned with flowing DI water onto the conductors of the FFC, and dried with an air duster spray (VWR International).
  • an FFC was attached onto the skull with Metabond adhesive cement before mesh implantation.
  • subcutaneous tunnel was made around the neck by inserting a bent 16-G needle.
  • the microcatheter was threaded through the needle, which was then removed, leaving the microcatheter under the skin.
  • mesh injection the microcatheter was retracted, the mesh electronics were placed under the skin.
  • the VO pads were then aligned with DI water onto the conductors of the FFC, and dried with an air duster spray.
  • UV light glue (Visbella) was applied on the VO pads and cured with handheld UV flashlight (Vansky). The incision in the neck region was closed by silk sutures.
  • FIGs. 2A-2B illustrates acute and chronic recording setup.
  • FIG. 2A for acute recording, the input/output (VO) region of the mesh electronics is aligned onto an FFC placed next to the neck, which is connected to an amplifier and a recording computer (not shown).
  • FIG. 2B for chronic recording, the mesh is threaded underneath the skin around the head and the VO region is aligned onto the FFC fixed on the skull.
  • each rat was returned to a cage place on a 37 °C heating pad. The activity of the rats was monitored until it was fully recovered from anesthesia.
  • Buprenex (Buprenorphine, Patterson Veterinary Supply) analgesia was given intraperitoneally at a dose of 0.05 mg per kg body weight every 12 hours for up to 72 hours post-surgery.
  • Laser Doppler Flowmetry measurement was used to evaluate cerebral blood flow before and right after mesh injection. First, a 1.2 cm long midline incision in the scalp to expose the skull bone. After the tissues and muscle on right side of the skull were removed, a 1.5 mm diameter dimple was drilled according to the following stereotaxic coordinates: anteroposterior, 0 mm; mediolateral, 5 mm. The LDF probe was fixed on the dimple with Krazy glue to monitor the blood flow. The LDF data was acquired with LabChart software (AD Instruments).
  • Rats with implanted mesh electronics were anaesthetized with 300 mg kg -1 of ketamine (Patterson Veterinary Supply) and transcardially perfused with ice-cold 30 ml saline and 30 ml 4% paraformaldehyde (PFA, Electron Microscopy Sciences) at specified times post-injection, followed by decapitation.
  • the scalp skin was cut and the exposed skull was removed by bone cutters (Fine Science Tools).
  • the brain was dissected from the bottom of the skull by cutting the connecting tissues and blood vessels, and was stored in 4% PFA for 1-2 days at 4 °C.
  • the brain was then transferred to in 15% sucrose solution (Sigma- Aldrich) in saline until the brain sinks (1-2 days) and then stored in 30% sucrose solution in saline at 4 °C until the brain sinks.
  • the brain was trimmed and placed in optimum cutting temperature (OCT) compound (Tissue-Tek) in a cryomold cup (Tissue-Tek) for 30 minutes.
  • the cryomold cup was then placed in 2-methylbutane (Sigma- Aldrich) in dry ice until the OCT turns white.
  • the frozen OCT block containing the brain was then glued on a metal holder in dry ice with more OCT compound.
  • the metal holder was then placed in cryostat (Leica Biosystems) for at least 1 hour.
  • the brain was then cut into 20 micrometer and 50 micrometer slices and transferred onto glass slides (Sigma-Aldrich).
  • Ibal and GFAP staining 20 micrometer brain slices were fixed in 4% PFA for 10 minutes, followed by rinsing in PBS for 3 times. The slices were then sequentially incubated with 0.5% Triton X-100 for 10 minutes, 3% BSA for 1 hour, and 1:200 primary antibodies, anti-Ibal (FUJIFILM Wako Pure Chemical Corp.) or anti-GFAP (Thermo Fisher Scientific) overnight, followed by rinsing in PBS for 3 times. The slices were then incubated with secondary antibodies (Vector Laboratories) labeled with Cy5 and Cy3, respectively, for 1 hour and rinsed with PBS for 3 times. Finally, the slices were mounted with Pro LongTM Gold Antifade Mountant with DAPI (Thermo Fisher Scientific).
  • IgG staining 20 micrometer brain slices were fixed in 4% PFA for 10 minutes, followed by rinsing in PBS for 3 times. The endogenous peroxidase activity was inhibited by incubating in peroxidase suppressor (Thermo Fisher Scientific) for 30 minutes and rinsed with PBS for 3 times. The slices were then sequentially incubated with 3% BSA for 1 hour, and anti-Rat IgG (Thermo Fisher Scientific) overnight, followed by rinsing in PBS for 3 times. The slices were then stained with DAB Peroxidase (HRP) Substrate Kit (Vector Laboratories). Finally, the brain slices were dehydrated with 70% ethanol for 2 minutes twice, and 100% ethanol for 2 minutes twice, and mounted with coverslips.
  • HRP DAB Peroxidase
  • Hematoxylin and Eosin Stain Kit 50 micrometer brain slices were labeled with Hematoxylin and Eosin Stain Kit (Vector Laboratories).
  • Fluorescence images were acquired on an Olympus FV1000 upright confocal microscope (BX61). 405, 559, and 635 nm laser sources were used with water immersion 20x objective as the excitation sources for DAPI, Cy3 and Cy5, respectively. All fluorescence images were acquired by Olympus Fluoview software v2.1.
  • Digital camera images of IgG-stained slices were acquired with an eyepiece camera (DCC1240C, Thorlabs Inc.) equipped with a manual zoom lens (MLH-10X, CBC Group), images were taken with ThorCam uc480 image acquisition software.
  • Optical images of IgG- and H&E-stained slices were acquired with a Nikon inverted microscope (Eclipse Ti-S) equipped with a Qlmaging camera and NIS-Elements Imaging Software.
  • Electrophysiology recording The electrophysiology of rats with implanted meshes was recorded with the FFC connected to an Intan RHD 2132 amplifier evaluation system (Intan Technologies). Electrophysiological recordings were acquired with a 20 kHz sampling rate and a 60 Hz notch filter.
  • penicillin solution 2000 units / 50 microliter, Sigma- Aldrich
  • penicillin solution was loaded into a 1-ml syringe with a 30-G needle.
  • the needle was bent and inserted into the cortex (anteroposterior, -2 mm; mediolateral, 2 mm; dorsoventral, 1.50 mm) and fixed on the skull with Metabond adhesive cement.
  • the penicillin solution was injected by pushing the plunger. After recording for 30 minutes, rats were euthanized by cardiac perfusion.
  • NSS neurological severity scores
  • MCAO middle cerebral artery occlusion
  • CCA common carotid artery
  • ECA external carotid artery
  • ACA anterior cerebral artery
  • the mesh-like flexible endovascular probe loaded into a microcatheter fixed on a syringe can be implanted by inserting the microcatheter to the MCA/ ACA bifurcation (without occlusion) followed by manual injection (FIG. 3A).
  • the microcatheter can only reach the MCA/ ACA bifurcation, the saline flow in the microcatheter can carry the probe much deeper into one of the smaller branches.
  • the microcatheter is retracted, leaving the mesh probe implanted inside the brain.
  • the bottom view of the perfused and dissected rat brains confirms the implantation into MCA and AC A branches (FIGs. 3B, 3C), where the typical injection depth exceeds 1 cm pass the MCA/ACA bifurcation.
  • FIG. 3A illustrates a microcatheter loaded with the mesh electronics is inserted from the ECA opening to the MCA/ACA bifurcation. With manual injection, the mesh electronics is implanted deeper into the MCA or ACA branch.
  • FIGs. 3B and 3C are images of the bottom of the dissected and perfused rat brains with meshes in MCA (FIG. 3B) and ACA (FIG. 3C). Zoom-in views of the MCA/ACA bifurcation show the meshes maintain their elongated shape in the micron-scale vessels.
  • the design of the flexible endovascular probes was considered and how they meet the key constraints for implantation into blood vessels by syringe injection.
  • the structure of the probes was designed based on an in-vivo recording tool termed injectable mesh electronics, where the polymer-based ultra-flexible mesh-like electronic devices can be loaded into a syringe needle and injected into rodent brains.
  • injectable mesh electronics an in-vivo recording tool
  • histology studies have shown that the brain implanted tissue-like ultra-flexible mesh electronics do not elicit inflammatory immune response and show full tissue healing.
  • the mesh region includes metal electrodes embedded in polymer-based mesh-like substrate, that is delivered to the targeted brain region, while the I/O region is left outside and later connected to the recording computer.
  • the injection depth can be ascertained by tracking the location of the I/O region during implantation.
  • the structure of the mesh electronics probe was designed based on the following considerations. First, injection depth from the ECA to MCA/ACA bifurcation for rats ranges between 1.5 - 1.8 cm, thus the length of the mesh region was designed to be ⁇ 2 cm to ensure that the major segment inside the blood vessels is highly porous, to prevent blockage of the blood flow.
  • the entire length of the probe was designed to be ⁇ 9 cm, as the mesh stem is threaded under the skin around the neck for the I/O region to be fixed on the skull.
  • a circa 10 micrometer thick guide wire (FIG. 4B) was defined on the middle ribbon (other ribbons are circa 1 micrometer in thickness), stem and I/O regions.
  • the distribution of the 16 of 80-micrometer electrodes spans over 1 cm, to probe different brain regions.
  • FIG. 4C a summary of the branch selectivity shows that 85% (11 out of 13) of mesh probes with 25-micrometer guide wires were implanted into MCA, 56% (5 out of 9) of mesh probes with 50-micrometer guide wires were implanted into MCA, while 83% (5 out 6) of mesh probes with 75-micrometer guide wires were implanted into ACA.
  • FIG. 4D The side view of a brain with a probe in MCA (FIG. 4D) reveal several important features.
  • the mesh probe maintained its extended shape without crumpling.
  • the individual electrodes and the mark of the mesh tip were easily identifiable from the optical images through the vessel wall.
  • the ultra-flexible mesh region was rolled up in the vessel, ‘squeezing’ the electrodes to the midline.
  • Representative multichannel recordings yielded well-defined signals in all 16 channels.
  • the fluctuation amplitude (200-400 microvolts) and the dominant frequency (1-3 Hz) recorded are characteristic of the delta wave local field potentials (LFPs) in isoflurane anaesthetized rats.
  • FIGs. 4A-4D illustrate branch- selective implantation.
  • FIG. 4A is a schematic of the mesh electronics with the ultra-flexible mesh device region at left tapering into the stem in the middle and I/O region at right.
  • FIG. 4B shows magnified views of the mesh region (marked in a) containing 16 Pt electrodes (top image). The middle line is the thick SU-8 guide wire.Tiled bright-field optical microscopy images of mesh regions with 25, 50 and 75 micrometer wide guide wires (bottom image).
  • FIG. 4C illustrates the percentage of meshes with different guide wire thickness injected into MCA and ACA.
  • FIG. 4D shows the side view of a rat brain with mesh in MCA. Zoom-in views show the mark of the mesh tip and Pt electrodes.
  • FIG. 4E illustrates acute in vivo 16-channel recording using mesh electronics injected into ACA.
  • the mean spike frequency and amplitude from 11-20 minutes are 31.5 +/- 3.5 / minutes and 1.77 +/- 0.40 mV, respectively.
  • a latent phase lasted for circa 4 minutes after penicillin administration (FIGs. 5D, 5E) before epilepsy onset, and then showed a burst-suppression pattern where high frequency spikes appeared around 10, 13, and 17 minutes.
  • the burst firing activity around the 17th minute shows periodic field potential waves (frequency: 0.88 Hz, peak width: 95.8 +/- 20.5 ms, amplitude: 2.89 +/- 0.24 mV) followed by a train of fast and narrow spikes (frequency: 14.65 Hz, peak width: 1.9 +/- 1.0 ms, amplitude: 0.71 +/- 0.24 mV) (FIG. 5D, iii). Comparison of the recording data in MCA and ACA reveal several important characteristics.
  • the epilepsy spikes spread to the cortex (MCA territory) faster than the olfactory bulb (ACA territory), which agrees with the previous literature that penicillin-induced epileptic activity begins focally, and then spread to other brain regions and cause generalized epilepsy.
  • MCA territory the cortex
  • ACA territory the olfactory bulb
  • the spike frequency, amplitude, shape and latent time in the cortex region is also consistent with previous reports of rats treated with intracortical penicillin administration.
  • the burst-suppression pattern with 3-4 minutes period recorded from the olfactory bulb shows similar pattern observed from rat olfactory bulb mitral cells, which fired with long bursts separated by long silent intervals, with a period of circa 4 minutes.
  • the periodic field potential waves followed by spike trains show the same firing behavior with the spontaneous activity in the olfactory bulb, where the field potential is dominated by slow oscillations in synchrony with the respiratory rhythm followed by gamma bursts (fast spike train) in each respiratory cycle.
  • FIGs. 5A-5E illustrate acute recording of epilepsy spikes.
  • FIG. 5A is a schematic of penicillin injection into rat brains with meshes implanted in MCA (FIGs. 5B and 5C) and ACA (FIGs. 5D and 5E).
  • the top images of FIGs. 5B and 5D illustrate penicillin-enduced epilepsy recorded by a representative channel from meshes in MCA (FIG. 5B) vs. ACA (FIG. 5D).
  • the middle images of FIGs. 5B and 5D illustrate frequency changes vs. time post penicillin injection.
  • the color bar shows the power levels.
  • the bottom images of FIGs. 5B and 5D illustrate zoom-in views of the spikes at different time points.
  • FIGs. 5A is a schematic of penicillin injection into rat brains with meshes implanted in MCA (FIGs. 5B and 5C) and ACA (FIGs. 5D and 5E).
  • 5C and 5E show the number of spikes with amplitude over 1 mV per minute recorded by meshes in MCA (FIG. 5C) vs. ACA (FIG. 5E).
  • the epilepsy spikes spread to the MCA region faster than the ACA region. After epilepsy onset, the spikes recorded by the MCA mesh reached constant frequency, while those recorded by the ACA mesh showed fast spiking in waves every several minutes.
  • the spikes in ACA region show periodic oscillations followed by fast and narrow spikes.
  • the isoflurane concentration was changed to modulate its firing frequency (FIG. 6C). Specifically, the recording started with an isoflurane concentration of 1.5% for 5 minutes, followed by 2% isoflurane for 8 minutes, and 0.5% isoflurane for 5 minutes. Right after the concentration was increased to 2.0%, the firing frequency dropped immediately, after a brief slow recovery, the firing activity was suppressed. Switching to 0.5% isoflurane immediately recovered the spikes, which eventually disappeared, probably due to the prolonged exposure to the high concentration isoflurane.
  • FIGs. 6A-6C illustrate acute recording of single-unit spikes.
  • FIG. 6A shows periodic single-unit spikes recorded by a mesh in ACA.The original recording trace is shown at the top and after 250-6,000 Hz band-pass filtering is shown at the bottom.
  • FIG. 6B shows singleunit spikes sorted from the data shown in FIG. 6A.
  • FIG. 6C illustrates changes of firing frequency with different isoflurane concentration, where higher concentration (2.0%) decreased and eventually suppressed firing, while lower concentration (0.5%) temporarily recovered firing.
  • LDF Laser doppler flowmetry
  • Representative LDF traces of mesh implantation in MCA and ACA show that compared to the baseline flow (i.e., 100%), LDF immediately after MCA implantation fluctuated between 60% to 140%, while LDF after ACA implantation stably increased to -130%, indicating that mesh in ACA does not reduce the cerebral blood flow.
  • the mesh in MCA initially reduced the blood flow and later recovered to a level much higher than the LDF required to induce stroke, which should be stabilized below 30% of the baseline for 90 minutes.
  • NSS neurological severity scores
  • FIGs. 7A-7B show representative LDF of implantation in MCA vs ACA.
  • LDF fluctuated between 60% to 140%
  • ACA mesh injection in ACA
  • LDF stably increased to -130%.
  • Histology studies were carried out 28 days post-implantation in MCA, as neointimal formation after rat artery stenting reached maximal at 28 days, causing significant thickening of the vessel walls, and the ischemic damage of the rat MCAO models started to recover 28 days post-operation.
  • BBB blood-brain barrier
  • IgG immunoglobulin G
  • the mesh was embedded in the vessel wall near the brain tissue.
  • the vessel wall thicknesses of the contralateral and ipsilateral hemispheres are 21.3 +/- 3.1 micrometers and 18.5 +/- 1.7 micrometers measured from 5 brain slices that are 600 micrometers apart (FIG. 8C), which confirmed that mesh implantation did not result in neointimal formation commonly observed after vascular stenting.
  • FIG. 8D confocal fluorescence microscopy images of the lateral cerebral cortex within the MCA territory are shown in FIG. 8D. The tissue samples were stained with antibodies for Ibal and glial fibrillary acidic protein (GFAP), and DAPI, to label microglia, astrocytes, and nuclei, respectively.
  • GFAP glial fibrillary acidic protein
  • the numbers of microglia counted from both hemispheres from 5 brain slices that are 600 micrometers apart are 37.2 +/- 3.0 on the contralateral side, and 36.8 +/- 5.5 on the ipsilateral side, while the number of astrocytes are 147.4 +/- 63.6 on the contralateral side, and 148.6 +/- 37.1 on the ipsilateral side.
  • FIGs. 8A-8E illustrates chronic histology.
  • FIG. 8A illustrates a digital camera image of a representative IgG-stained brain slice 28 days post-implantation in MCA.
  • FIG. 8B illustrates zoom-in views of the contralateral and ipsilateral MCA cross-sections from the H&E-stained slice from the regions highlighted by the larger boxes in FIG. 8A. The arrow highlights the mesh embedded in the vessel wall.
  • FIG. 8C shows MCA vessel wall thickness measured from H&E images of 5 slices that are 600 micrometers apart.
  • FIG. 8D illustrates confocal fluorescence microscopy images of the contralateral and ipsilateral cortexes from the regions highlighted by the smaller boxes in FIG. 8A. The brain slice was stained with antibodies for Ibal and GFAP, and DAPI.
  • FIG. 8E shows the number of microglia (Ibal) and astrocytes (GFAP) counted from fluorescence images of 5 slices that are 600 micrometers apart.
  • Ibal micro
  • this example shows the delivery of flexible electronics into 100-micron scale vessels in rodents for minimally invasive neural recording without open-skull surgery has been introduced. It has been shown that this endovascular interface can be selectively implanted into small vessel branches that are not accessible to microcatheters, and achieve neural recording across the vessel walls with single-unit resolution. Histology studies of the electronics/vessel wall/brain tissue interface showed minimal immune response and longterm stability.
  • a reference to “A and/or B”, when used in conjunction with open-ended language such as “comprising” can refer, in one embodiment, to A only (optionally including elements other than B); in another embodiment, to B only (optionally including elements other than A); in yet another embodiment, to both A and B (optionally including other elements); etc.
  • the phrase “at least one,” in reference to a list of one or more elements, should be understood to mean at least one element selected from any one or more of the elements in the list of elements, but not necessarily including at least one of each and every element specifically listed within the list of elements and not excluding any combinations of elements in the list of elements.
  • This definition also allows that elements may optionally be present other than the elements specifically identified within the list of elements to which the phrase “at least one” refers, whether related or unrelated to those elements specifically identified.
  • “at least one of A and B” can refer, in one embodiment, to at least one, optionally including more than one, A, with no B present (and optionally including elements other than B); in another embodiment, to at least one, optionally including more than one, B, with no A present (and optionally including elements other than A); in yet another embodiment, to at least one, optionally including more than one, A, and at least one, optionally including more than one, B (and optionally including other elements); etc.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Vascular Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)

Abstract

La présente divulgation concerne de manière générale une électronique injectable qui peut être insérée dans un sujet, par exemple, dans un vaisseau sanguin. Certains modes de réalisation comprennent un dispositif comprenant des éléments électriques qui sont injectés dans un sujet, par exemple pour permettre la détection de neurones et/ou stimuler une réponse. Dans certains cas, le dispositif peut être encapsulé partiellement par un cathéter, pour être inséré dans un sujet. Dans certains cas, les éléments électriques peuvent être en communication électrique avec une carte de circuit imprimé externe par l'intermédiaire de contacts électriques sur le dispositif par l'intermédiaire d'un composant de jonction. Dans un ensemble de modes de réalisation, le composant de jonction comprend un fil-guide qui confère des propriétés appropriées (par exemple, une raideur mécanique d'au moins 30 nN m) à une partie du dispositif, par exemple, pour permettre l'insertion du dispositif dans un vaisseau sanguin. Certains modes de réalisation concernent également des systèmes et des procédés de fabrication et d'utilisation dudit dispositif.
PCT/US2021/045679 2020-08-14 2021-08-12 Systèmes et procédés pour sondes endovasculaires souples à l'échelle micrométrique pour l'enregistrement neuronal Ceased WO2022036050A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063066042P 2020-08-14 2020-08-14
US63/066,042 2020-08-14

Publications (1)

Publication Number Publication Date
WO2022036050A1 true WO2022036050A1 (fr) 2022-02-17

Family

ID=80247365

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2021/045679 Ceased WO2022036050A1 (fr) 2020-08-14 2021-08-12 Systèmes et procédés pour sondes endovasculaires souples à l'échelle micrométrique pour l'enregistrement neuronal

Country Status (1)

Country Link
WO (1) WO2022036050A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119745326A (zh) * 2024-12-18 2025-04-04 西安交通大学 嗅球僧帽细胞层神经电生理信号的空间阵列电极及方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070255379A1 (en) * 2003-06-04 2007-11-01 Williams Michael S Intravascular device for neuromodulation
US20080015459A1 (en) * 2002-08-21 2008-01-17 New York University Brain- machine interface systems and methods
US20130206454A1 (en) * 2010-08-26 2013-08-15 Acandis Gmbh & Co. Kg Electrode for medical applications, system having such an electrode, and method for producing such an electrode
US20160287325A1 (en) * 2011-11-07 2016-10-06 Medtronic Ardian Luxembourg S.A.R.L. Endovascular Nerve Monitoring Devices and Associated Systems and Methods
US20190046119A1 (en) * 2011-10-04 2019-02-14 Thomas James Oxley Methods for sensing or stimulating activity of tissue
US20200008924A9 (en) * 2015-10-20 2020-01-09 Nicholas Lachlan OPIE Endovascular device for sensing and or stimulating tissue

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080015459A1 (en) * 2002-08-21 2008-01-17 New York University Brain- machine interface systems and methods
US20070255379A1 (en) * 2003-06-04 2007-11-01 Williams Michael S Intravascular device for neuromodulation
US20130206454A1 (en) * 2010-08-26 2013-08-15 Acandis Gmbh & Co. Kg Electrode for medical applications, system having such an electrode, and method for producing such an electrode
US20190046119A1 (en) * 2011-10-04 2019-02-14 Thomas James Oxley Methods for sensing or stimulating activity of tissue
US20160287325A1 (en) * 2011-11-07 2016-10-06 Medtronic Ardian Luxembourg S.A.R.L. Endovascular Nerve Monitoring Devices and Associated Systems and Methods
US20200008924A9 (en) * 2015-10-20 2020-01-09 Nicholas Lachlan OPIE Endovascular device for sensing and or stimulating tissue

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119745326A (zh) * 2024-12-18 2025-04-04 西安交通大学 嗅球僧帽细胞层神经电生理信号的空间阵列电极及方法

Similar Documents

Publication Publication Date Title
JP6399968B2 (ja) 生体吸収性基板上の埋め込み型バイオメディカルデバイス
Fattahi et al. A review of organic and inorganic biomaterials for neural interfaces
US9907475B2 (en) Implantable micro-component electrodes
US9427164B2 (en) Insertable neural probe with flexible structure
US20060173397A1 (en) Ophthalmology implants and methods of manufacture
US10355229B2 (en) Methods and systems for scaffolds comprising nanoelectronic components
JP5074521B2 (ja) 電極アレー
JP5039539B2 (ja) ナノ構造表面の医療装置応用
Cobo et al. Parylene-based cuff electrode with integrated microfluidics for peripheral nerve recording, stimulation, and drug delivery
Kim et al. A hybrid silicon–parylene neural probe with locally flexible regions
Knaack et al. In vivo characterization of amorphous silicon carbide as a biomaterial for chronic neural interfaces
US10369255B2 (en) Scaffolds comprising nanoelectronic components for cells, tissues, and other applications
CN101616630A (zh) 电极阵列
US8639311B2 (en) Sensing probe comprising multiple, spatially separate, sensing sites
US20210290949A1 (en) Nerve cuffs, methods of fabricating the same and methods of use
US20160302682A1 (en) Nanoscale wire probes for the brain and other applications
CN101861129A (zh) 用于塑造或提拉人体中正常或扩张组织的装置
US20180224433A1 (en) Techniques and systems for injection and/or connection of electrical devices
WO2022036050A1 (fr) Systèmes et procédés pour sondes endovasculaires souples à l'échelle micrométrique pour l'enregistrement neuronal
US20170172438A1 (en) Systems and methods for injectable devices
Chang et al. In vivo use of a nanoknife for axon microsurgery
US20180328884A1 (en) Interfaces for syringe-injectable electronics
US12441973B2 (en) Cell scaffold comprising an electronic circuit
KR20230124639A (ko) 흡수가능 복합 바이오물질로 형성된 전도성 스캐폴드및 이의 용도
Moxon et al. Long-term recordings of multiple, single-neurons for clinical applications: the emerging role of the bioactive microelectrode

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 21856694

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 21856694

Country of ref document: EP

Kind code of ref document: A1